- research2guidance · the mhealth app market has been experiencing new dynamics since the market...

Analysis and comparison of the app portfolio of top 12

Pharma companies (v.2)

22nd October 2014

Site License: Access allowed with multiple users within pre-determined

geographical location of your organization

© research2guidance 2014

Pharma App Benchmarking

2014 How Pharma companies make use of mobile apps

www.mHealthEconomics.com

© research2guidance 2014 Site License 2

Content

1. Scope of the report ................................................................................................................................. 3

2. About research2guidance ....................................................................................................................... 4

3. Management summary ........................................................................................................................... 5

4. Pharma app market: How the Pharma industry uses the mobile app channel today ............................ 7

4.1. The Pharma app portfolio size and performance................................................................................ 7

4.2. The 10 main app categories of Pharma ............................................................................................. 11

4.3. Platform preference and geographical reach of Pharma apps ......................................................... 14

5. App portfolio comparison ..................................................................................................................... 16

5.1. Comparison of app portfolio performance ....................................................................................... 16

5.2. Comparison of target groups, regional focus and governance models ........................................... 19

6. Pharma companies’ app profiles ........................................................................................................... 22

6.1. Abbott/Abbvie app profile ................................................................................................................ 22

6.2. AstraZeneca app profile .................................................................................................................... 26

6.3. Bayer Healthcare app profile ............................................................................................................ 29

6.4. Bristol-Myers Squibb app profile ...................................................................................................... 32

6.5. GlaxoSmithKline app profile ............................................................................................................. 35

6.6. Johnson&Johnson app profile ........................................................................................................... 38

6.7. Merck app profile .............................................................................................................................. 41

6.8. MSD app profile ................................................................................................................................. 43

6.9. Novartis app profile ........................................................................................................................... 46

6.10. Pfizer app profile ........................................................................................................................... 50

6.11. Roche app profile .......................................................................................................................... 53

6.12. Sanofi app profile .......................................................................................................................... 56

7. Options for a better app portfolio performance ................................................................................... 59

8. Pharma app catalogue (list of apps by company and platform) .......................................................... 62

9. List of figures ......................................................................................................................................... 93


1. SCOPE OF THE REPORT

The report analyzes the global app publishing activities of the 12 leading Pharma companies on Android

and iOS devices. The research provides a detailed picture of which app categories Pharma companies

concentrate on, how many apps they have published, which user groups they target, how they organize

their app business and how successful they are.

The report analyzes app publishing activities on three levels:

Level 1 - Pharma app publisher industry view: The first chapter provides an overview of how Pharma

companies are making use of the app channel today and how this has changed over the last 12 months.

Level 2 - Comparison of Pharma app activities: In the second part of the report, the companies are being

analyzed on a company level and compared against each other.

Level 3 - Pharma app publisher profiles: The third part provides detailed profiles of the companies’ app

activities. It also highlights the most successful apps for professional and private users (based on

downloads).

Companies in scope: Abbvie/Abbott, Astra Zeneca, Bayer HealthCare, Bristol-Myer Squibb,

GlaxoSmithKline, Johnson&Johnson, Merck, MSD, Novartis, Pfizer, Roche and Sanofi.

Apps in scope: All apps available in the Apple App Store (iTunes store) and in Google Play which have been

published by one of the app publishing entities of the companies in scope.

Regional scope: Global

The research behind these reports has not been commissioned or sponsored in any way by any business,

government, or other institution.

research2guidance

Data provided by:


Diabetes App Market Report 2014

• Market size

• Key players

• Country markets

• Best Practices

• Trends

• 114 pages

2. ABOUT RESEARCH2GUIDANCE

research2guidance is a strategy advisory and market research company. We concentrate on the mobile

app eco-system. We are convinced that mobile health solutions will make a difference to people’s lives

and that the impact on the healthcare industry will be significant. We provide insights to make it happen

and to successfully lead your business.

research2guidance

Oranienburger Strasse 27, 10117 Berlin, Germany

+49 30 609 89 33 60

Other reports:

Find more insights about the mHealth app market on:

www.mHealtheconomics.com

mHealth App Developer Economics 2014

• Market size

• Connected health elite

• Successful mHealth app publishing

• 43 pages

• Free download

http://www.mhealtheconomics.com/


3. MANAGEMENT SUMMARY

Since Apple has created the new app ecosystem, the mHealth app market segment has attracted much

attention and created hope among the mHealth app developer community.

mHealth apps promise to improve the medical adherence, let doctors get into direct contact with

patients, help hospital reduce hospital re-admissions and length of stay or reduce costs of medical trials to

name a few.

Pharma companies have taken on these opportunities and actively published apps since the beginning of

the market in 2008/2009. This benchmarking study examines how far the 12 largest Pharma companies

got after five years of app publishing and whether or not they have reached a comparable market position

in the app economy as they have in the healthcare industry.

Pharma companies are active app publishers: The leading 12 Pharma companies have published 497

unique apps. A unique app is an app which might have been published in different countries or as

platform versions, but its functionality, design and usability are same. Altogether these 497 unique apps

represent 736 app titles available for iOS and Android.

The app portfolio is diverse: 32% of apps by the leading 12 Pharma companies are medical reference

apps that mainly provide information about symptoms, medications, treatments, devices, location of

hospitals or doctors’ offices. The second largest group (20%) of apps published by Pharma companies are

medical condition management apps. These apps are supposed to support patients or just health

conscious people to manage their disease or health e.g. diabetics, asthmatics or fitness enthusiasts. The

rest of the app portfolio of Pharma companies includes a broad variety of other app categories including

recipes, games, diagnosis tools, pill reminders, eyesight testing, doctor’s appointment management and

many more.

The companies use neither common design standards nor internal app promotions to increase visibility

and download numbers.

The majority (57%) of apps target private users and are published on iOS (64%).

The reach of the app portfolios is limited: The number of all-time downloads Pharma companies have

been able to generate with their app portfolios is 6.6m1. This is a very low reach compared to mHealth

app market leaders like MyFitnessPal which alone has more than 70m downloads (on iOS and Android)

and more than 6m active users from just one app. The share of downloads which come from the leading

Pharma companies top 3 apps varies between 22% (Novartis) and 99% (Merck). 9 out of 12 Pharma

companies have generated more than 50% of downloads with just three apps. The 12 leading Pharma

companies have altogether less than 1m active users. Only four out of 12, boast more than 100,000 active

users (Sanofi, Merck, Johnson&Johnson and GSK).

Pharma companies use a decentralized app publishing approach: Most of the Pharma companies publish

their apps under multiple publishing units. The spectrum ranges from 1 (Bristol-Myers Squibb) to 17

(Novartis).

The app portfolio is not globally available: Almost half of Pharma company’s app publishing entities

target only local markets. 49% of the total 65 publishers that stand behind the Pharma app portfolios

publish their apps in 3 or less countries.

1 All-time downloads: accumulated downloads since launch until September 2014


The performance benchmarking of the leading Pharma companies shows significant differences in

downloads, apps users, app categories, country focus, governance models and target groups. None of the

app portfolios has a significant impact in the mHealth app market. There are only two apps which have

generated more than a million downloads since they have been launched (GoMeal and MerckPTE).

In order to have a bigger impact on the mHealth app market Pharma companies must thoroughly improve

their app publishing approach in 7 main areas:

1. Apply design guidelines and internal app referencing 2. Concentrate app activities on where the market demand is 3. Focus on mHealth data collection 4. Open up APIs2 to build a connected app portfolio 5. Strengthen Android app presence and make use of cross platform app development tools 6. Become truly global 7. Align app publishing governance and competencies

It is also questionable whether or not Pharma companies will ever become good enough app publishers to

be able to compete against the 100% dedicated start-up companies or big tech giants like Apple or Google

which have recently shown much interest in the mHealth app market.

Each Pharma company should challenge and question their current performance in the app market. The

companies should start a discussion around whether or not it will be a good investment of time and

money to develop and publish the next 700 apps the next five years. Otherwise, Pharma might be better

skilled to undertake a role of an investor, incubator, app aggregator or mHealth data provider?

What this all means is that before going forward in the same way as the last five years, Pharma companies

should rethink their mHealth app strategy. Otherwise they will remain an industry with low impact on the

mHealth app market. This is not a serious threat to their core business today, but in five years it might be.

2 API: Application Programming Interface


Pharma

companies have

been active app

publishers but

with a few

exceptions, their

apps don’t belong

to the leading

mHealth apps.

4. PHARMA APP MARKET: HOW THE PHARMA INDUSTRY USES THE MOBILE APP CHANNEL

TODAY

The mHealth app market has been experiencing new dynamics since the market of connected wearables

(e.g. activity trackers, connected watches and blood pressure sensors) became a mass market. Only after

these devices have become available to the masses, has the mHealth data potential been seriously

perceived as the new oil of the healthcare industry.

Companies like Validic and Human API have built their business models around apps

that capture health data from an increasing number of self-tracking and monitoring

app and device users. The introduction of the HealthKit platform from Apple and the

expected similar moves from its competitors like Google and Samsung gives the

mHealth app developer community much hope. Namely, these movements will

potentially lead to thousands of apps which collect, store, aggregate, analyze, display

and share health and fitness data.

The resulting explosion of health data stored on many different silos will create

inexhaustible opportunities for the healthcare systems to improve treatment, drugs

and reduce cost.

This mega trend is creating an enormous threat and also a great challenge for the

Pharma industry. Already today millions of patients synchronizing their e.g. blood

pressure, temperature, glucose levels, mood, skin pictures, activities, food intake and

many more metrics in order to manage their health condition and potentially in the future better

understand the impact of a therapy or a drug. This direct channel (apps) which patients use on a

continuous basis is potentially so valuable that one does not understand why Pharma companies do not

play a much more visible role in the mHealth app economy.

4.1. THE PHARMA APP PORTFOLIO SIZE AND PERFORMANCE

Since last year the app portfolio of the leading 12 Pharma companies has grown by 61% to 497 unique

apps3 released on Apple App Store and Google Play. Altogether the number of apps available in both

stores is 736.

Around 45% of these apps have been published on both platforms (iOS and Android), an increase from

18% in 2013.

3 Unique app: an app that might be published in different country or platform versions but with one functionality, design and usability. All these version are counted as one unique app


12 Pharma

companies use 65

different app

publisher entities

Figure 1: Number of apps published by top Pharma companies 2013 and 2014

Most of the Pharma companies have a decentralized app publishing strategy.

The 12 Pharma companies’ apps have been published by 65 different publisher

entities. Novartis and Johnson&Johnson have the most decentralised publishing

strategy with 17 different registered entities each. Bristol Myers Squibb on the

other hand, has hired only 1 publisher for their app portfolio.

The impact of the app portfolio expansion on downloads

The enlarged app portfolio and additional year in market has had its impact on the number of all-time

downloads. All-time downloads are the accumulated downloads of each app since the app’s launch.

Within a year, the total all-time download number has increased by 197% (yoy4), reaching 6.62m. The

average lifetime download number per unique app has increased from 7,300 to 13,300.

4 Yoy: year on year

© research2guidance October 2014

TOP PHARMA COMPANIES HAVE 63% MORE UNIQUE APPS IN THE APP

STORES THAN LAST YEARNumber of unique apps

Comments: Unique number of apps of the top 12 Pharma companies. An app that islisted on iOS and Android is counted as one unique app.Source: Source: research2guidance, Prioridata

305

497

0

100

200

300

400

500

600

2013 2014


1% of Pharma

apps have

generated 57%

of all-time

downloads

Figure 2: Pharma's all-time app downloads 2013 and 2014

The number of monthly active users has risen to 972,000. This means that 15% of iOS and Android

smartphone or tablet users who have downloaded a Pharma app use it at least once a month. This is in

line with the market average.

Only a few apps get all the attention and downloads

Within the 497 unique apps there is only a very small number of apps which have generated a notable

number of downloads. The most downloaded 5 apps alone represent 57% of the total downloads. These

apps are “GoMeal” by Sanofi Aventis, the periodic system education app “PTE” by

Merck, “Pill Reminder” by Bayer Healthcare, “Aquafresh Brush Time” by GSK and

“Similac Baby Journal” by Abbott.

Only two apps (“GoMeal” and “Merck PTE”) are in the “one million download league”.

The top 20 apps account for 3 out of 4 downloads of all Pharma apps. The “long tail” of

Pharma apps is substantial.

Only the two most downloaded apps have more than 100,000 active users. Another ten have more than

10,000 active users. These figures include users from iOS and Android, tablet and smartphone and all

country versions of these apps.

The vast majority of Pharma apps are not used by a notable number of users.


WITHIN A YEAR, THE NUMBER OF TOTAL DOWNLOADS HAS INCREASED BY

197%Number of alltime downloads

Comments: Total global app downloads of entire app portfolio of the top 12 PharmacompaniesSource: research2guidance, Prioridata

2,230

6,620

0

1,000

2,000

3,000

4,000

5,000

6,000

7,000

2013 2014

Tho

usa

nd

s


57% of

Pharma apps

target private

users

Figure 3: Download share of top 5, 10 and 20 Pharma apps

The majority of mHealth apps that are available in the app stores target private users. Still Pharma

companies have a much higher focus on providing mobile app services for healthcare

professionals than the rest of the market.

43% of their unique apps target doctors, nurses, clinicians and business partners. These

apps cover a broad range of use cases including e.g. apps that help doctors educate their

patients about vascular health (Abbott), application helping clinicians estimate a patient's

baseline risk of in-hospital major bleeding (Astra Zeneca), apps for the diagnosis and

treatment of cardiovascular diseases (Bayer Healthcare) and other.

Most of these apps do not have any access restriction (e.g. doctors ID, or passcodes provided by the

Pharma sales representative) and, if they have an educational purpose, can be used by private users as

well.

Download and usage share is not higher for these apps than of apps which target private users directly.


Share of downloads of top 20, top 10 and top 5 pharma apps on iOS and Android

Comments: Download share is based on all time downloads of top 5,10,20 appsSource: research2guidance, Prioridata

1% OF PHARMA APPS REPRESENT 57% OF ALL DOWNLOADS

76.0%69.7%

57.7%

Top 20 apps Top 10 apps Top 5 apps


Figure 4: Download and MAU5 share by target group of Pharma apps

4.2. THE 10 MAIN APP CATEGORIES OF PHARMA

The app portfolio of Pharma companies is as diverse as the rest of the mHealth app market. The apps

from Pharma companies can be categorized into 10 main categories. Please note that there is an overlap

between these main categories as most of the apps have a relatively broader value proposition. To

categorize an app for the purpose of this report, apps have assigned to one of the main categories based

on their main use case. The 10 app categories Pharma companies concentrate on are:

Medical reference apps: Pharma companies publish apps which provide reference to symptoms, diseases, drugs or medical treatments. Quite often they also help users find the nearest doctor’s office or a hospital. These medical reference apps account for 33% of all unique apps available on Apple App Store and Google Play published by one of the 12 leading Pharma companies. An example is Medinfo by Novartis that allows health care professionals (HCPs) to search for the latest medical information, submit inquiries and report adverse events for Novartis products.

5 MAU: Monthly Active User


43% OF PHARMA APPS TARGET PROFESSIONALS THAT CAPTURE 26% OF

THEIR ACTIVE USERS

Professional and private app, download and MAU share

MAU: Monthly active userSource: research2guidance, Prioridata

Professional 26%

Professional 27%

Professional 43%

Private 74%

Private 73%

Private 57%

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

MAU

Downloads

Apps


Figure 5: Pharma's app categories

Medical condition management is the second largest group of apps (20%). A typical example in this category is the “Astma” app by GSK. The app targets asthma patients and lets them manage their disease better. The app includes a diary, graphics which show historical test results, pollen, fine dust, UV, ozone levels, helpful tips and a reminder function for regular testing. Other supported medical conditions are multiple sclerosis, diabetes, acromegaly, headache, pain or addiction.

Tools accounts for 8% of all apps. Tools mainly target HCPs and support a diagnosis or calculate a dose of a drug. An example is the ”Index Hemato” app by Roche. The app provides a selection of classification and prognostic index of hematological malignancies. A typical calculator is the “Clearance - GFR Calculator” app by Abbott. This calculator estimates the creatinine clearance based on serum concentration and age.

Kids: 6% of apps published by Pharma companies provide services for child health and baby care. These apps provide advice on proper teeth-brushing (e.g. “Aquafresh Brush Time” by GSK), track the overall development of a baby including sharing features and photo album (e.g. “Similac Baby Journal” by Abbott) or manage vaccination (e.g. “Vaximate” by Pfizer).

Health improvement apps represent 6% of apps released by Pharma companies. They cover a broad spectrum of mobile supported use cases. This includes general health tracking apps which track water and food consumption as well as sport and brain activities. They also support the user to stay in a better mood e.g. “Smidge 2.0” by Pfizer. This category also lists health games e.g. “Happy Nurse” by J&J, a simple jump and run game and step counters like “WalkAlong” by GSK and motivation apps e.g. “Rewards” by Novartis.

Compliance apps (3%) are mainly medical reminders like “Pill Reminder+” by Bayer Healthcare. Some simply support the regular taking of the birth control pills e.g. “PillReminder - Denk an mich” by Sanofi.

Medical education (3%) apps make use of videos, graphics, tests and tutorials to educate the HCPs, students, teachers or non-professional users about the periodic system (e.g. “Merck PTE” by Merck), human anatomy (e.g. “Vascular Videos: Private Education” by Abbott) or symptoms (e.g. “Understanding Acute Coronary Syndrome (ACS)” by Astra Zeneca).

Woman: 2% of apps target women exclusively. Such apps give advice on pregnancy, sexuality or fertility (e.g. “Aşkı Şansa Bırakma” by Bayer Healthcare).


MEDICAL REFERENCE AND CONDITION MANAGEMENT ARE THE MAIN APP

CATEGORIES

Distribution of app by category

Comments: App category share is based on number of unique appsSource: research2guidance, Prioridata

Medical reference33%

Medical condition management

20%

Tool8%

Kids6%

Health improvement

6%

Compliance3%

Medical education3%

Women2%

Nutrition1%

Wellness1%

Other17%


Nutrition and Wellness: Nutrition and wellness apps each represent only 1% of the total app portfolio of Pharma companies. There are apps that provide tips for a better sleep (e.g. “SleepHelp” by Pfizer), recipe apps (e.g. “Recipes2Go” by Pfizer) or beauty tips (e.g. “ACUVUE® DEFINE” by J&J).

There are many more mobile use cases which are addressed by Pharma companies and which have been summarized in the other category section (17%). These apps include e.g. PHRs, eyesight training, pet care or doctor’s appointment to name a few.

Although the app portfolio of Pharma companies covers all app subcategories which exist in the mHealth

app market, they put importance on other use cases. The main difference is the quasi non-presence in the

most popular mHealth app markets’ categories: fitness, wellness and nutrition/weight loss apps (not

shown in the graph).

This suggests that Pharma companies’ app portfolio is closely related to their core products and not

necessarily to the main market needs.

Figure 6: Differences between Pharma app portfolios and the mHealth app market


PHARMA COMPANIES HAVE A DIFFERENT APP FOCUS COMPARED TO OTHER

MHEALTH APP PUBLISHERSComparison of the pharma app portfolio with the rest of the mHealth app market

Total mHealth app market is represented by a sample consiting of top 200 listedmHealth apps on Apple App Store and Google Play of categories health& fitnessand medical and paid and free apps, August 2014, n=1,600Source: research2guidance, Prioridata

0.4%

0.8%

1.8%

2.8%

7.9%

20.2%

33.6%

20.2%

10.1%

8.7%

7.6%

2.0%

12.9%

23.7%

Fitness

Wellness

Women

Medical education

Tool


Medical reference

Total mHealth app market Pharma app market


4.3. PLATFORM PREFERENCE AND GEOGRAPHICAL REACH OF PHARMA APPS

Pharma companies have started to develop Android versions of their apps, but iOS is still the number one

platform in terms of the number of available apps, downloads and active users. 64% of the Pharma apps

are available on iOS compared to 36% for Android. All-time downloads and user numbers of iOS apps are

in the same relation to Android as the app count. The emphasis on iOS is in contrast to the Android’s

global dominance6. One reason for this loyalty to iOS might be that Pharma companies have originally

started publishing their apps on iOS and have just not had the resources or, as a result of unsatisfactory

app results, motivation to develop and maintain an Android version of their iOS apps. Another reason

might be that Pharma companies also tend to concentrate on the USA market which has a higher iOS

share than the global average (see next chapter).

The iOS focus means that only 1/3 of Pharma’s app portfolio targets the largest and fastest growing app

market (Android).

Figure 7: Pharma's platform choice and their user base

Almost half of Pharma companies’ app publishing entities target only local markets. 49% of the 65

publishers who stand behind the leading Pharma companies’ app portfolios release apps in 3 or less

countries. In fact, 59% of these local publishers focus on just one country.

6 IDC: Q2 2014: Android 84,7% and iOS 11,7% market share of shipments


IOS IS THE NUMBER ONE PLATFORM CHOICE FOR PHARMA COMPANIES AND

THEIR APP USER BASEPlatform preference and reach: Android vs. iOS

Comments: Based on all apps published on both platformsSource: research2guidance, Prioridata

Share of apps by platform Share of total downloads Share of monthly active users

64% 67%

36% 33%

65%

35%


Figure 8: Number of markets targeted by Pharma's apps


ALMOST HALF OF PHARMA APP PUBLISHERS ARE ONLY TARGETING LOCAL

MARKETS

Local49%Global

51%

Share of geographical reach of pharma company‘s app publishers

1 country59%

2 countries

28%

3 countries

13%

Comments: based on the geographical reach of 66 publishering entities of pharmacompanies that have published their apps globally or locally (up to 3 countries)Source: research2guidance, Prioridata


5. APP PORTFOLIO COMPARISON

The app activities of the leading Pharma companies show significant differences in number of apps

published, total downloads, active user base and app category focus.

5.1. COMPARISON OF APP PORTFOLIO PERFORMANCE

All Pharma companies have a preference for iOS. Most, if not all, launched their first apps on the iOS

platform and kept Apple users as their main target group since then, despite the fact that the addressable

market for Android phones and tablets is 3-5 times bigger, depending on the region.

There are four Pharma companies which have published around 100 apps for iOS and Android. Sanofi is

the leading Pharma app publisher with its 107 available apps on iOS and Android. The iOS share varies

between 55% (GSK) and 98% (Roche).

The more apps in app portfolio, the higher the share of apps developed for Android. Small publishers stick

to iOS.

Figure 9: Number of apps published by Pharma per platform

Despite the large app portfolios, there are only 3 companies that have been able to generate more than

one million downloads with their apps.

Download numbers are not the only valid performance indicator, but if a publisher is not able to gain a

significant reach within the target group via downloads, any app-related business model is likely to fail.

Sanofi is the only company in the panel that has generated more than 2 million all-time downloads for

their 107 apps. On the other hand, GSK which boasts the second largest app portfolio has attracted only

700,000 downloads since the beginning of their app activities.


Number of apps published by platform

Source: Research2guidance, Prioridata

43

1

18

18

29

8

21

47

3

42

18

15

64

24

31

52

45

18

42

57

8

56

42

30

Sanofi-Aventis

Roche

Pfizer

Novartis

MSD

Merck

Johnson&John…

GlaxoSmithKline

Bristol-Myers…

Bayer…

AstraZeneca

Abbott/Abbvie 45

60

98

11

104

63

49

26

74

25

107

50 100

SANOFI AND GSK ARE THE MOST ACTIVE APP PUBLISHERS

67%

70%

57%

73%

55%

67%

61%

74%

63%

96%

60%

iOS share

70

69%


The download

share of the

top 3 apps

varies between

22% (Novartis)

and 99%

(Merck)

Sanofi;

the only

company that

counts more

than 2m

downloads

Sanofi, Merck and Johnson&Johnson are clearly the app publishers with the highest reach

within the Pharma company benchmarking. Nevertheless, compared to mHealth app

market leaders like MyFitnessPal (70m downloads), Azumio or WebMD (both around

20m downloads) their app portfolio is far away from being competitive in the mHealth

market.

AstraZeneca, Bristol-Myer Squibb, Novartis, Pfizer and Roche do not show any significant

uptake of their app portfolio on any of the platforms.

Figure 10: All-time app downloads per company and platform

This picture even more disappointing if the share of the three most successful apps of an app portfolio is

taken into consideration. The top 3 apps’ share is for 9 out of 12 companies’ higher than 50% of all

downloads. The app portfolios of Abbott/Abbvie, GSK, Merck, Roche and Sanofi rely to

more than 80% on the performance of their top 3 apps. Merck’s app portfolio’s

performance is backed up to 97% by the Merck PTE app which is an educational app that

provides detailed information and visual aids of the periodic table of the elements. Sanofi

has generated most of its downloads with the GoMeal app (58%), an app that mainly

targets diabetics, provides food recommendation and tracking as well as activity tracking.

The download numbers of the top 3 apps per company include various country versions

as well as a secondary platform copy. This clearly shows that the Pharma company app

portfolio performance just depends on a very few apps.

On the other hand, this also means that the vast majority of apps have none or only little impact on the

app market. Most of the apps have attracted a few hundred downloads and hardly any active users.

The large “long-tail” of apps from Pharma companies as well as the lack of apps with a wide reach in the

market shows that Pharma companies have not yet found the right approach to the mHealth app market.


ONLY THREE PHARMA COMPANIES HAVE REACHED MORE THAN A MILLION

DOWNLOADS WITH THEIR APP PORTFOLIOTotal all time app downloads per company and platform

Source: research2guidance, Prioridata

0 500,000 1,000,000 1,500,000 2,000,000 2,500,000

Sanofi

Roche

Pfizer

Novartis

MSD

Merck

Johnson&Johnson

GSK

Bristol-Myers Squibb

Bayer Healthcare

AstraZeneca

Abbott/Abbvie

Android iOS


MSD and Roche

would have to

generate almost

twice as many

downloads as

J&J to have the

same amount of

active users

Figure 11: Each Pharma company's top 3 apps as a share of the company's total downloads

It is evident that the download of an app is a prerequisite for its usage. At the same time, the most

downloaded apps are not used after a few weeks or even days.

Thanks to the success of the top apps of Sanofi (“GoMeals”), Merck (“Merck PTE”), Johnson&Johnson (“7

Minute Workout”) and GSK (“Aquafresh”), these companies have also managed to maintain the largest

active user base. All four companies have more than 100,000 active users. Sanofi again leads the

benchmarking with more than 300,000 active users. A Monthly Active User is defined as a user who opens

an app at least once a month (MAU).

The share of active users in relation to the number of downloads (MAU share) is a good

indication of how well the apps succeed in engaging with their users over time. With only

12% MSD and Roche (13%) has the lowest and Johnson&Johnson (22%) the highest MAU

share in the benchmarking. This translates to a very challenging situation for MSD and

Roche. The company has to generate almost twice as many downloads with their app

portfolio to reach the same user number as Johnson&Johnson.

All of the apps in the sample are free to download. The main objective of the Pharma’s apps

is therefore not to generate additional revenue source, but more likely to create brand

awareness, offer additional services and to get into direct contact with the persons who

take their medications. Looking at the number of apps, the number of users all Pharma

companies have and assuming significant effort that has been put into the development of

the app portfolio, it is safe to say that they have not reached their goals yet.

For example, a company like Novartis has 70 apps listed in the Apple App Store and Google Play store and

reaches out to only around 30,000 users, whereas small start-up companies like MySugr (Diabetes

management app) claims to have almost 150,000 users of only one of their apps.


TOP 3 APPS HAVE A SIGNIFICANT IMPACT ON THE APP PORTFOLIO

PERFORMANCE OF MOST PHARMA COMPANIESShare of total downloads from top3 apps per company (iOS & Android combined)


58%

73%

19%

10%

29%

97%

64%

76%

38%

38%

12%

77%

19%

5%

18%

7%

16%

1%

6%

4%

20%

15%

11%

4%

9%

5%

13%

5%

6%

1%

5%

4%

18%

12%

11%

2%

14%

17%

50%

78%

48%

1%

25%

17%

24%

36%

66%

16%

0% 20% 40% 60% 80% 100%

Sanofi

Roche

Pfizer

Novartis

MSD

Merck

Johnson&Johnson

GlaxoSmithKline


Bayer Healthcare

AstraZeneca

Abbott/Abbvie

#1 #2 #3 Other


Figure 12: Monthly active users and share of MAU per Pharma company

5.2. COMPARISON OF TARGET GROUPS, REGIONAL FOCUS AND GOVERNANCE

MODELS

Compared to the mentioned best practice examples in the report, Pharma companies have a higher share

of apps which target professional users (e.g. doctors, nurses, and teachers). Despite this, at least 1/3 of

each of the 12 leading Pharma companies’ app portfolios still target private users. Namely, Bayer

Healthcare (58%), GSK (83%), Johnson&Johnson (86%), Novartis (56%), Pfizer (73%) and Sanofi (67%)

reach out to groups like patients with chronic diseases, health conscious and fitness oriented people,

pregnant women, parents or kids rather than doctors, hospitals or insurance companies (professional

users).

Also the “professional” part of the Pharma’s app portfolio does not target only one, very specific group,

but rather all doctors e.g. by providing reference for all kinds of symptoms, medicine or therapies.

This means that the app portfolios of Pharma companies can be compared with the rest of the mHealth

app market and that the structure of the portfolio is not an argument for a lower reach and performance.


Monthy active users and share of MAU per company

Source: research2guidance & PrioridataMAU: Monthly active userMAU share: No. of MAU/all time downloads

DESPITE THE LARGE APP PORTFOLIO OF MOST PHARMA COMPANIES ONLY 4 HAVE MORE THAN 100,000 ACTIVE USERS

0%

5%

10%

15%

20%

25%

0

50

100

150

200

250

300

350

Tau

sen

de

MAU Share of MAU


Figure 13: Target group - private vs. professional - shares per Pharma company

Compared to the vast majority mHealth app publishers, Pharma companies seem to find it more

challenging to align their mHealth app know-how. One indicator of this is the number of app publishers a

company uses for their app portfolio. AstraZeneca (11), Johnson&Johnson (17) and Novartis (17) are all

supported by more than 10 different app publishing entities. This is not a hard evidence for a non-

coordinated app publishing, but a large number of publishers means that communication and re-use of

existing concepts, codes in other regions is getting more difficult.

Figure 14: Number of app publishers by company


MOST PHARMA COMPANIES MAINLY TARGET PRIVAT USERS WITH THEIR APP

PORTFOLIOTarget group share of apps


67%

36%

73%

56%

50%

31%

86%

83%

36%

58%

36%

39%

33%

64%

27%

44%

50%

69%

14%

17%

64%

42%

64%

61%

0% 20% 40% 60% 80% 100%

Sanofi

Roche

Pfizer

Novartis

MSD

Merck

Johnson&Johnson

GlaxoSmithKline


Bayer Healthcare

AstraZeneca

Abbott/Abbvie

Private Professional


NOVARTIS, ASTRAZENECA AND JOHNSON&JOHNSON HAVE THE MOST

DECENTRALIZED APP PUBLISHING GOVERNANCE MODELNumber of app publishers of each of the top 11 global pharma companies


4

2

3

17

2

1

17

2

1

3

11

2

0 2 4 6 8 10 12 14 16 18

Sanofi-Aventis

Roche

Pfizer

Novartis

MSD

Merck

Johnson&Johnson

GlaxoSmithKline


Bayer Healthcare

AstraZeneca

Abbott


Besides this, all Pharma companies in this benchmarking analysis are global players, but

their app activities are present in only a few countries. 10 out of 12 companies

generate more than 50% of their total app downloads in only 3 countries. The main app

market for 6 out of 12 companies is the USA followed by France, Germany and the UK.

China and other Asian app markets do not constitute a significant share of downloads

for the Pharma app portfolios.

Novartis is the company which generates the biggest share of downloads (57%) outside

of its top 3 markets. On the other hand, Abbott/Abbvie has the largest share of its

downloads generated in one, single market: 88% of all downloads come from the US.

Figure 15: Top 3 markets per company and their share of total downloads

The comparison of the Pharma companies’ app portfolios shows a significant effort in terms of the

number of apps published. To a large extent, they all target private users. In terms of performance,

neither of the leading Pharma companies has reached a footprint in the app market which would be

comparably equal to the position they have in the traditional healthcare market.

Sanofi, Johnson&Johnson and Merck have gained the highest reach in the app market with their app

portfolios boasting more than 1 million downloads and 150,000 active users. Most of the downloads and

users come from just one or two apps, making it difficult to justify the effort that has been put into the

rest of the app portfolio and this is the case not only for these, above mentioned three leaders.


11 OUT OF 12 PHARMA COMPANIES MAKE MORE THAN 50% OF THEIR APP

DOWNLOADS IN ONLY 3 COUNTRIESTop 3 countries and their share of total downloads

Source: Research2guidance, Prioridata

Company Country Share Country Share Country Share

Abbott USA 88% Italy 2% Canada 2% 92%

AstraZeneca France 30% Netherlands 24% Germany 6% 60%

Bayer Healthcare Brazil 53% Turkey 10% Germany 8% 71%

Bristol-Myers Squibb France 62% USA 23% UK 3% 88%

GlaxoSmithKline UK 36% Italy 12% Romania 11% 60%

Johnson & Johnson USA 41% China 9% UK 7% 57%

Merck Germany 52% Spain 5% China 5% 62%

MSD Italy 42% France 28% UK 6% 76%

Novartis USA 32% Japan 5% Turkey 5% 43%

Pfizer USA 30% Taiwan 13% Canada 9% 53%

Sanofi-aventis USA 55% Germany 22% Brazil 4% 81%

Roche USA 68% Canada 10% Germany 2% 80%

Top 1 Top 2 Top 3 Share of top 1-2-3

countries

10 out of 12

companies

generate more

than 50% of

their total app

downloads in

only 3 countries


6. PHARMA COMPANIES’ APP PROFILES This chapter summarizes the app activities of the Pharma companies included in the report.

6.1. ABBOTT/ABBVIE APP PROFILE

Abbott/Abbvie concentrates on apps that address professional users. 68% of published apps target HCPs.

All apps are published under Abbott and Abbvie brand. Abbot has listed 45 apps on the Apple App and

Google Play Store. Their apps have been downloaded 341,000 times. Total active user number of all the

apps is 55,000, which gives an average of a little more than 1,200 active users per app.

The perceived governance model for their app business is closed and in-house. Of all the Pharma

companies in consideration, Abbott uses one of the most centralized publisher approach to publishing,

with only two publishing entities engaged. They have started to follow a more open and partnership-

based approach. This includes first developer day events and a high profile partnership with Calico, a

Google start-up company that focuses on health and well-being, in particular the challenge of aging and

associated diseases.

Figure 16: Abbot app - key metrics

# of apps # of

publishers

# of downloads # of MAUs Avg. DL per app Target group

Private Profess.

30 15 2 213,000 128,000 55,000 7,100 8,500 32% 68%

Top private use app Similac Baby Journal

Top professional use app CLEARANCE - GFR CALCULATOR

Their app portfolio consists of medical reference apps (36%). They also focus more on women as

compared to the rest of the Pharma companies. Their best performing app is a simple Baby tracking app

“Similac Baby Journal”, which accounts for more than 75% of all downloads.


Figure 17: Abbot app - category shares


Women18%

Tool16%

Education11%


9%

Pet care7%

Health improvement

2%


ABBOTT TOP PRIVATE USE APP: SIMILAC BABY JOURNAL

App store description:

A tracking app that tracks baby's feeding, sleeping, diaper changes and growth. The app gives tips and

advice also from other users. A social feature also helps to share information with the family and

pediatrician via email.

Platforms: Android, iOS

Business model: Free

Top country: USA

Target group: Private

Downloads: 267,500

MAU: 43,000

Average rating: 4.2

Release date: Dec. 20, 2010 (iOS)


ABBOTT TOP PROFESSIONAL USE APP: CLEARANCE - GFR CALCULATOR


This is a calculator tool to estimate the creatinine clearance given the creatinine serum concentration and

age. The clearance of creatinine is calculated with five methods: CDK-EPI, MDRD simplified (4 variables),

Cockroft (if weight available), Mayo quadratic formula and Jelliffe.

Creatinine serum concentration can be entered in mg/dl or in mol/L. If available, weight and height are

used to calculate the body surface area (BSA) and convert the clearance from the standard reference

surface area of 1.73m to the real BSA.

Platforms: iOS


Top country: Canada

Target group: Professional

Downloads: 7,500

MAU: 900

Average rating: 4.2

Release date: Jun. 30, 2011


6.2. ASTRAZENECA APP PROFILE

AstraZeneca focuses on apps that target HCPs. Their reach and success in the app ecosystem is very

limited with only ten thousand downloads and thousands of monthly active users. Their app portfolio

includes 60 apps (iOS and Android versions of the same unique app are counted as separate apps) with a

clear preference for iOS.

AstraZeneca uses a decentralized app governance model. They have 11 different app publishers listed on

the two major app platforms. In June 2014, they have announced the first partnership with Exco in Touch

a mHealth data capture and clinical trial mobile solution provider.

Figure 18: AstraZeneca app - key metrics

# of apps # of

publishers


Private Profess.

42 18 11 55,000 3,000 8,000 1,300 150 35% 65%

Top private use app Migrain-e

Top professional use app Trivia hart- en

AstraZeneca predominantly publishes medical reference apps which constitute 69% of their app portfolio.

Figure 19: AstraZeneca app: category shares

Medical reference

69%

Medical condition

management

15%

Education5%

Tool5%

Health improvement

2%

Work efficiency2%

Other2%


ASTRAZENECA TOP PRIVATE USE APP: MIGRAIN-E


Migrain e-CH is a personal migraine diary. This tool helps migraine patients easily document their

migraine attacks: intensity, frequency, timing, symptoms and trigger factors. Migrain e-CH also supports

the physician to better control the migraine. The app can record doctor appointments.

The app saves contact details of the user, physician, medical specialists and persons to be notified in case

of incidents.

A summary of the seizure diary can be printed and sent by e-mail. Thus the physician is able to optimize

the treatment.

Platforms: iOS


Top country: Switzerland


Downloads: 7,200

MAU: 900

Average rating: 3.9

Release date: Aug. 9, 2011


ASTRAZENECA TOP PROFESSIONAL USE APP: DIAGNOSTICS DIFFICILES EN PNEUMOLOGIE


The app is a diagnosis apps for pulmonary diseases. In order to use the app doctors have to request a

password from AstraZeneca.

Diagnoses are listed in alphabetical order and are available in one click. The user can type in clinical signs

and in return get a diagnosis. The presentation of the result (diagnosis) is supported by tables and figures.

Platforms: iOS


Top country: France


Downloads: 5,200

MAU: 600

Average rating: 2.6

Release date: Nov. 12.2011


6.3. BAYER HEALTHCARE APP PROFILE

Bayer Healthcare has been one of the most active (in terms of number of apps) publisher among the

leading Pharma companies. They have almost 100 apps available for iOS or Android. The majority (60%) of

their apps target private users. Despite the efforts, they have not been able to attract a significant

number of downloads (587,000) or active users (91,000).

They recently shifted their focus from in-house app publishing to a more open approach using an

incubator model (“Grants4Apps”) to attract innovative mHealth app start-ups.

Figure 20: Bayer Healthcare app - key metrics

# of apps # of publishers


Private Profess.

56 42 3 302,000 285,000 91,000 5,400 6,800 60% 40%

Top private use app Hora da Pílula

Top professional use app Universo Médico

Current app portfolio is concentrating on providing medical reference and medical condition management

apps. In addition, with 15% of their apps they target pet holders and veterinarians.

Figure 21: Bayer Healthcare apps: category shares

Medical reference

26%

Medical condition

management

22%Pet care

15%

Women9%

Compliance8%

Tool7%

Health improvement

1%

Other12%


BAYER HEALTHCARE TOP PRIVATE USE APP: HORA DA PÍLULA


Simple reminder app including: daily reminders, customization of time settings, count of the remaining

pills.



Top country: Brazil


Downloads: 221,000

MAU: 31,600

Average rating: 3.9

Release date: Aug. 4, 2011 (iOS)


BAYER HEALTHCARE TOP PROFESSIONAL USE APP: UNIVERSO MÉDICO


The app is mainly a medical reference app that is available for the community of medical professionals.

The app gives professionals a number of useful services for their daily work. Highlights of the app:

consultation to P.R. Vade Mecum of drugs (leaflets), 18 medical calculators, ICD-10, atlas of the human

body, news and scientific content.



Top country: Brazil


Downloads: 72,500

MAU: 9,600

Average rating: 3.4

Release date: Aug. 31, 2011 (Andr.)


6.4. BRISTOL-MYERS SQUIBB APP PROFILE

Bristol-Myers Squibb is hardly present in the two largest app stores. Their app portfolio consists of 8 iOS

and 3 Android apps. Their apps have been able to attract neither the interest of private nor of

professional users yet.

Figure 22: Bristol-Myers Squibb app - key metrics



Private Profess.

8 3 1 2,000 500 370 250 170 43% 57%

Top private use app Continuum of Care

Top professional use app Mobile Merch

Figure 23: Bristol-Myers Squibb app - category shares

Medical reference

50%

Medical condition

management

30%

Other20%


BRISTOL-MYERS SQUIBB TOP PRIVATE USE APP: CONTINUUM OF CARE


This is a medical condition app that targets patients and requires a one-time activation code. The app

provides information for patients about atrial fibrillation and stroke prevention including: patient

education, healthy living suggestions, dosing alert and prescription reminders.

Platforms: iOS


Top country: United Kingdom


Downloads: 1,200

MAU: 100

Average rating: NA

Release date: Oct. 10, 2013


BRISTOL-MYERS SQUIBB TOP PROFESSIONAL USE APP: MOBILE MERCH


The app “Mobile Merch” targets pharmacists. It helps pharmacy professionals to access merchandising

advice and important KPIs; create custom 3D merchandising recommendation based on the number of

shelves, contact customer service and / or medical information.



Top country: France


Downloads: 650

MAU: 100

Average rating: 2.3

Release date: Feb. 26, 2013 (iOS)


6.5. GLAXOSMITHKLINE APP PROFILE

GSK has an app portfolio that consists of 57 iOS and 47 Android apps. They mainly target private users

(78%), but have been only succeeded in generating a little more than 700,000 downloads. Total active

user base for all their 104 apps is 137,000 (average 1,300 users per app). GSK is one of the few Pharma

companies with a significantly higher download share of Android rather than iOS apps.

mHealth at GSK is also engaged in various projects in developing regions. They often develop these

projects in partnership with mobile operators like Vodafone.

GSK’s smartphone apps have been published centrally (by 2 publishing entities) and mainly internally.

With their “Open Wants” platform GSK has recently started to put more emphasis on attracting app

developers and to open up their boundaries.

Figure 24: GlaxoSmithKline app - key metrics



Private Profess.

57 47 2 184,000 520,000 137,000 3,200 11,000 78% 22%

Top private use app Aquafresh Brush Time

Top professional use app 918 ClinKit

GSK has put much importance on apps for kids as compared to the other Pharma app publishers. Most

apps for kids are in form of the localized version of one tooth brush app “Aquafresh”, which is the most

used app published by GSK. In some countries GlaxoSmithKline has partnered with some of the biggest

brands to promote the app. In Germany, for example, the app “Aquafresh Brush Time“ is called “ODOL-

MED3 PUTZZEIT“ (Odol being a mouthwash). In the Czech Republic the app is called “Odol Čas čištění“. In

the UK/ Australia GSK has teamed up with Macleans (toothpaste company) and published the app under

the name “Macleans Nurdle Time”.

Figure 25: Figure 9: GlaxoSmithKline app: category shares

Medical condition

management

34%

Medical reference

28%

Kids26%

Health improvement

4%

Tool2%

EHR1%

Other5%


GLAXOSMITHKLINE TOP PRIVATE USE APP: AQUAFRESH BRUSH TIME


The Aquafresh app supports kids to brush all parts of their teeth using gamification elements and

rewards. A song is played while a timer counts down for two minutes.

Each complete brush earns them “Nurdle stars” that can be used at the Nurdle Shop, where they can

“buy” virtual gear to dress up their very own Nurdle.



Top country: United Kingdom


Downloads: 233,000

MAU: 46,400

Average rating: 3.9

Release date: Jun. 14, 2013 (iOS)


GLAXOSMITHKLINE TOP PROFESSIONAL USE APP: 918 CLINKIT


918 ClinKit is a reference tool to be used by physicians participating in the COMPLEMENT A+B clinical

research study.



Top country: USA


Downloads: 3,400

MAU: 400

Average rating: 3.0

Release date: Jul. 26, 2013 (Andr.)


6.6. JOHNSON&JOHNSON APP PROFILE

Johnson&Johnson has a clear focus on private app users. They use 17 different app publisher entities for

their app business. This also includes apps published by its daughter company Wellness &Prevention

which is the publisher of the most successful Johnson&Johnson app: 7 Minutes Workout, a health

improvement app. With almost 750,000 downloads and 1,500 ratings (US Apple App Store, average 4.5) in

10-month period, it is one of the best performing apps targeting private users.

Their app portfolio consists of 42 iOS and 21 Android apps. J&J’s average number of downloads is higher

than Pharma’s average, but these mainly come from one app. The rest of the app portfolio has not

generated a notable number of downloads.

Figure 26: Johnson&Johnson app - key metrics



Private Profess.

42 21 17 924,000 252,000 250,000 22,000 12,000 89% 11%

Top private use app The Johnson&Johnson official 7 Minute Workout App

Top professional use app 领医迈 Neck Medical Mai

Johnson&Johnson’s app portfolio specializes in apps that provide services for contact lenses’ owners,

eyesight testing and education.

Figure 27: Johnson&Johnson app - category shares

Eyesight31%

Medical reference

22%

Medical condition

management

8%

Health improvement

3%

Kids3%

Education2%

Other31%


JOHNSON&JOHNSON TOP PRIVATE USE APP: JOHNSON&JOHNSON OFFICIAL 7 MINUTE WORKOUT APP


A fitness app that offers over 1,000 workouts split into 7 Minute Intervals.

Platforms: iOS, Android


Top country: USA


Downloads: 754,000

MAU: 156,000

Average rating: 4.7

Release date: Jan. 2014


JOHNSON&JOHNSON TOP PROFESSIONAL USE APP: NECK MEDICAL MAI ( 领医迈)


Neck Medical Mai is an educational app for the Chinese HCPs and students. The goal has been to build a

personalized online learning and academic exchange platform for healthcare professionals from all

disciplines and at all levels.

The app provides access to medical information anytime, anywhere.

The app includes a multi-directional interactive community to communicate with the country's top

experts who answer users’ questions.

Platforms: iOS


Top country: China


Downloads: 16,100

MAU: 2,500

Average rating: 4.4

Release date: Feb. 23, 2013


6.7. MERCK APP PROFILE

Merck’s app portfolio addresses mainly HCP users (69%). Merck is concentrating their app publishing

activities in one publisher entity. With 26 app Merck does not belong to the most active app publishers

but because of the success of the Merck PT app they belong to the more successful app publishers. The

app portfolio has reached more than 1.2 m downloads with 97% of these downloads coming from the top

app. All apps count 207,000 users. This also explains the high average number of downloads. The Merck

app portfolio is basically a one app initiative.

Figure 28: Merck app - key metrics

# of apps # of

publishers

# of downloads # of

MAUs

Avg. DL per app Target group

Private Profess.

18 8 1 907,000 305,000 207,000 50,400 38,000 31% 69%

Top private use app ieffect

Top professional use app Merck PTE HD

Their best performing app is an educational app. The Merck PTE explains the periodic system. The entire

app portfolio is a broad mix of apps that provide medical reference (35%), condition management (19%)

and medical education (11%).

Figure 29: Merck app - category shares

Medical reference

35%

Medical condition

management19%

Medical education

11%

Diabetes management

8%

Medical work management

8%

Other19%


MERCK TOP PRIVATE USE APP: IEFFECT


The app demonstrates a broad range of pigments coming from Merck. Pigments come with a description

and are presented in photos to illustrate the possible application scenarios.

Platforms: iOS


Top country: N/A


Downloads: 10,000

MAU: 2,000

Average rating: 3.3



MERCK TOP PROFESSIONAL USE APP: MERCK PTE HD


The Merck PTE app is an educational app. The app provides detailed information and visual aids of the

periodic table of the elements. It offers high-school and university students as well as teachers or

professors the opportunity to learn more about the chemical elements - from classification, element

features to the history of their discovery.

The app give access to all relevant details regarding the elements of the periodic table such as relative

atomic mass, melting point and boiling point, density, appearance and additional properties for each

individual element.



Top country: Germany


Downloads: 1,180,000

MAU: 200,000

Average rating: 4.5

Release date: Jun. 9, 2010 (iOS)

6.8. MSD APP PROFILE

MSD is an active app publisher with 74 apps listed on Apple App Store and Google Play. The majority

(61%) of their apps are developed for iPhones and iPads. The app portfolio equally targets professional

and private users. Within the benchmarking group, the average performance of the apps is one of the

lowest.

In addition to their own app publishing activities, MSD has been actively building up partnerships to

mobilize their content e.g. Skyscape app “The Merck Manual of Diagnosis and Therapy”. They have also

set up a digital health fund (GHI) to invest in innovative healthcare technology (not only mHealth). The

GHI fund portfolio includes companies like Welldoc and Preventive which offer medical condition

management solutions for diabetics and cardio patients.


Figure 30: MSD app – key metrics

The app portfolio of MSD puts a bigger emphasis on reminder apps (19%) compared to the benchmarked

companies. Similar to the rest of the Pharma app portfolios MSD also mainly publishes reference apps

(32%) and medical condition management apps (15%).

Figure 31: MSD app - category shares



Private Profess.

45 29 2 80,000 17,000 12,000 1,700 580 49% 51%

Top private use app iChemoDiary

Top professional use app Algorythmo CVM


Medication reminder17%Medical condition

management15%

Medical calculator10%

Diagnostic tool7%

Diabetes management4%

EHR P-D4%

EHR-D3%

Medical information3%

Eyesight2%

Fertility2%

Patient education1%


MSD TOP PRIVATE USE APP: ICHEMODIARY


iChemioDiary is a free app for iPhone that assists users in managing their chemotherapy and helps them

take control of symptoms, treatments and side effects.

Reports can be sent to user’s e-mail box and can be printed and shared with their doctor.



Top country: Belgium


Downloads: 28,000

MAU: 3,300

Average rating: 3.2

Release date: Oct. 16, 2009 (iOS)


MSD TOP PROFFESIONAL USE APP: ALGORITMO CVM

The algorithm CVM is a reference app for the diagnostic and therapeutic management of the patient at

risk for cardiovascular, renal and metabolic. The app target physicians and hospital pharmacists.



Top country: N/A


Downloads: 4,000

MAU: 400

Average rating: 4.1

Release date: June, 15, 2012 (iOS)

6.9. NOVARTIS APP PROFILE

Novartis mainly concentrates on publishing iOS apps. Their app portfolio consists of 52 iOS and 18

Android apps. Despite their large number of apps and a private target share of 55%, Novartis has not been

able to generate a substantial app download number or active user base. The average all-time download

number is comparably low, ranging between 1,700 and 3,000 downloads per app. In contrary to their

competitors, they do not have an app which significantly outperforms the rest of the app portfolio.

Novartis has the most decentralized app publishing strategy of all Pharma companies in the report (17

different publisher entities). They recently started to establish partnerships with technology players.

These partnerships include: Proteus Digital Health (health technology services provider), Sense.ly

(telemedicine, Oct. 2013), TicTrac (multiple sclerosis, May, 2014) and with Google regarding its smart

contact lenses project for diabetics. (July, 2014)

Figure 32: Novartis app - key metrics



Private Profess.

52 18 17 154,000 31,000 30,000 3,000 1,700 55% 45%

Top private use app My Migraine Triggers

Top professional use app NovartsiMag


Their app portfolio covers a broad spectrum of app categories with medical condition management e.g.

MyNet Manager for oncology patients, medical reference (21%) e.g. Clinical Trial Seek or health

improvement apps (19%) e.g. Lauffeuer step counter app, which aims to support a COPD campaign.

Figure 33: Novartis app - category shares

Medical condition

management

26%

Medical reference

21%

Health improvement

19%

Education7%

Eyesight6%

Tool4%

Work efficiency4%

Pet care3%

Other10%


NOVARTIS TOP PRIVATE USE APP: MY MIGRAINE TRIGGERS


The My Migrane Trigger app is a medical condition management app that is only intended for US

residents. The app allows users to keep track of your everyday activities, such as exercise, stress and

eating habits to help them identify their potential migraine triggers. It charts out daily log information into

customizable reports to let them easily understand which activities, foods and beverages are associated

with the onset of user’s headaches. The app allows sharing of results with doctors.



Top country: USA


Downloads: 18,100

MAU: 3,100

Average rating: 3.6

Release date: Oct. 1, 2012 (iOS)


NOVARTIS TOP PROFESSIONAL USE APP: NOVARTISIMAG


"Novartis image" tablet application gives users access to a number of different therapeutic expert

opinions on diseases, disease stages, diagnosis and treatment processes, patient’s life stories, etc. Users

can access information about the disease via audio and video quickly and easily. In addition, users have

access to Novartis magazine content on current topics and news: psychology, educational articles,and

articles on human resources.

Platforms: iOS


Top country: Austria


Downloads: 12,500

MAU: 2,700

Average rating: 4.9

Release date: Jun. 20, 2013


6.10. PFIZER APP PROFILE

Pfizer has published 31 iOS and 18 Android apps under 3 Pfizer publisher brands. The majority of Pfizer

apps targets private users (71% of all apps). Download and active user numbers are low.

On top of this, Pfizer has established some additional partnerships with mHealth app publishers e.g.

Epocrates and is also running joint projects with the Global mHealth Alliance. They occasionally use

Hackathons to get closer to the mHealth app developer community.

Figure 34: Pfizer app - key metrics



Private Profess.

31 18 3 74,000 67,000 21,000 2,400 3,700 71% 29%

Top private use app 健康小秘書 (Healthy young secretary)

Top professional use app 辉瑞医谷 (Pfizer medical valley)

The Pfizer’s app portfolio consists of 39% medical condition management apps e.g. “Min Hovedpine”

(headache), medical reference apps (19%) e.g. “Haemophilia Dosing Assistant”. Besides, 14% of their apps

are intended for kids/child health (14%) e.g. “VaxiMate”.

There is no app in the portfolio which has been able to raise significant user numbers.

Figure 35: Pfizer app - category shares

Medical condition

management

39%

Medical reference

19%

Kids14%

Eyesight4%

Nutrition4%

Tool4%Wellness

4%

Work efficiency4%

Health improvement

2%

Other6%


PFIZER TOP PRIVATE USE APP: 健康小秘書(Healthy young secretary)


This is a medical reference (including features from other app categories) app from Pfizer intended for the

Chinese app market. The app allows the user to record their health data, such as health management

logs, BMI, weight, blood pressure, heart rate, blood sugar, allergy records. It is also a medication

reminder, a hospital and clinic finder and a news app. It helps users check the progress of doctor-patient

registration and provides guidance for certain health examinations for common diseases.



Top country: Taiwan


Downloads: 25,600

MAU: 3,100

Average rating: 4.2

Release date: Sept. 7, 2012 (iOS)


PFIZER TOP PROFESSIONAL USE APP: PFIZER MEDICAL VALLEY 辉瑞医谷


This is Pfizer’s Chinese Medicine reference app for Chinese healthcare professionals. The app provides

features including one hundred free video lessons and allows their users to directly submit queries to the

Pfizer Medical Information professional team. The app references to the latest version of the specification

of prescription drugs in China and common medical formulas.



Top country: China


Downloads: 7,350

MAU: 1,100

Average rating: 3.8

Release date: Jul. 30, 2013 (iOS)


6.11. ROCHE APP PROFILE

Roche is mainly concentrating on Apple/iOS as the platform to publish their branded apps. The majority of

their apps target professional users. The most downloaded app is ACCU-CHECK, a diabetes management

app for Android.

Figure 36: Roche app - key metrics



Private Profess.

24 1 2 18,000 50,000 9,000 750 50,000 43% 57%

Top private use app ACCU-CHEK® 360° Diabetes Mgmt.

Top professional use app Index Hémato

Compared to the other leading Pharma companies, Roche is less active in the app market in terms of

number of apps. Nevertheless, Roche does not fall behind its competitors in terms of diversity. The app

portfolio includes e.g. a recipe app “Fettarm kochen”, a diagnostic tool app “Oncoscale” or a relaxation

app “Lung+ Pioneering Healthcare”.

Figure 37: Roche app - category shares

Compliance4%

Health improvement

4%Medical

condition management

8%

Medical reference

36%

Nutrition8%

Tool24%

Wellness4%

Other12%


ROCHE TOP PRIVATE USE APP: ACCU-CHEK® 360° DIABETES MGMT.


The ACCU-CHEK® 360° is a diabetes management app. The app incorporates a selection of reports that

helps the user to identify trends and patterns of blood sugar levels e.g. 3-day profiles, a reminder

function, a log book capturing meals (size, carbs, or calories), insulin, exercise, medications, blood

pressure, weight and health state, notes and photos. It also supports the sharing of the captured

information with the doctors via email or text message.

Platforms: Android


Top country: N/A


Downloads: 50,000

MAU: 7,300

Average rating: 4.0

Release date: Nov. 19, 2012


ROCHE TOP PROFESSIONAL USE APP: INDEX HÉMATO


The Index Hemato app is a reference app that assists hematologists and oncologists in treating their

patients. The app includes a selection of classification and prognostic index of hematological illnesses. The

goal is to provide doctors of with simple and functional information to define prognostic factors. The apps

helps doctors adapt treatment strategies according to international requirements, based on the

characteristics of a given patient and their disease.

Platforms: iOS


Top country: France


Downloads: 3,600

MAU: 400

Average rating: N/A



6.12. SANOFI APP PROFILE

Among the leading Pharma companies, Sanofi is one of the most active app publishers. Sanofi’s app

portfolio comprises of 64 iOS and 43 Android apps. Their apps mainly target private users (69%). Two

thirds of all-time downloads originate from iOS users.

The company has hired 4 publishing entities to develop their app portfolio. Sanofi has also made some

effort to establish digital (not only app publishing) competencies within the global and local organizations.

They have established digital country heads, digital classes at the Sanofi university and hired digital

experts from other industries.

Figure 38: Sanofi Aventis app - key metrics



Private Profess.

64 43 4 1,500,000 578,000 311000 23,000 13,000 69% 31%

Top private use app GoMeals

Top professional use app AFib Educator

The app portfolio of Sanofi Aventis is as broad as the portfolio of the other Pharma companies. The

company made the biggest impact with apps that support diabetics. In 2010 Sanofi closed an agreement

with AgaMatrix for the development, supply and commercialization of blood glucose monitoring (BGM)

solutions. In 2012 iBG Star was one of the first apps to track glucose levels with the help of a FDA cleared

sensor that can be plugged into the iPhone. The app created much market awareness at the time but lost

attention in the following years. The second app that addresses diabetics is GoMeals, an app that helps

diabetics with their diet and tracks their activity levels. Both apps account for more than 2/3 of the

Sanofi’s total app user base.

Figure 39: Sanofi Aventis app - category shares

Compliance4% Education

3% EHR1%

Health improvement

12%

Kids11%

Medical condition

management

21%

Medical reference

35%

Tool7%

Other6%


SANOFI AVENTIS TOP PRIVATE USE APP: GOMEALS


GoMeal is a medical condition management app that helps especially diabetics to make healthy lifestyle

choices at home and on the go. GoMeals includes tools for eating healthy, staying active, and tracking

blood glucose levels.



Top country: USA


Downloads: 1,211,000

MAU: 182,200

Average rating: 3.3

Release date: Nov. 4, 2009 (iOS)


SANOFI AVENTIS TOP PROFESSIONAL USE APP: AFIB EDUCATOR


The app provides healthcare professionals with an interactive resource to help illustrate how AFib can

affect the heart; it visually demonstrates the symptoms, risks and management strategies of atrial

fibrillation (AFib) to educate patients. The app uses animation, diagrams and x-ray images to illustrate the

impact of AFiB on the heart.



Top country: N/A


Downloads: 60,800

MAU: 7,500

Average rating: 3.9

Release date: Mar. 17, 2010 (iOS)


7. OPTIONS FOR A BETTER APP PORTFOLIO PERFORMANCE

The top 12 Pharma companies have published 736 apps (497 unique apps) on the Apple App Store and

Google Play. They have made a substantial effort to reaching out to both private users and, to a lesser

degree, to HCPs. Since their first apps were launched in 2008, Pharma companies have failed to have a

significant impact on the mHealth app market. Only a handful of apps have generated a substantial user

numbers among their target groups.

There are some conclusions that can be drawn from the results of the benchmarking for;

1. Why are Pharma companies not successful? and 2. What are the options Pharma has to improve its market position?

The analysis of the 736 apps showed that apart from the some improvement potential in the usability,

design and functionality, there are more systematic areas with scope for improvements. In order to

improve their app performance, Pharma companies should take measures related to the following areas.

Apply design guidelines and internal app referencing: So far Pharma companies have not used the potentials of cross-referencing between their apps. They also do not use common style guides for their app portfolio which could improve their app visibility as well as strengthen corporate identity in the app market. This is becoming even more than before, given that more than 100,000 mHealth apps are listed in the two major app stores.

Concentrate app activities on where the market demand is: The app portfolio is built around the core products of the Pharma companies and not around the actual market demand. For example, if a company is specializes in the treatment of hematological diseases, the app portfolio reflects that. Apps in this case would provide references to latest research, support diagnosis and facilitate information exchange with/between the experts. There exists an app market for such products, but there are other segments e.g. health tracking, weight loss, fitness or diabetes condition management, which attract more users. An app category strategy should concentrate on the current and expected market areas with high user demand.

Focus on mHealth data collection: The mHealth app market is still at a very early stage and successful business models might change over the next 5 years. But it is most likely that the user generated health data will become a major asset in the future. App portfolios that concentrate on the collection of e.g. the activity levels, calories burned, glucose levels or blood pressures of millions of users will have all options at hand to have a profitable app business in the future. For instance, they could transfer the knowledge to help the industry develop better medications, therapies and medical devices.

Open up APIs7 to build a connected app portfolio: There is a growing number of apps which connect to other mHealth apps to read out user generated activity and medical data. By doing so such apps have become more valuable (e.g. Loose it, Fitbit, EveryMove) for their users as well as for their creators. With iOS 8, Apple has created a platform to allow for an exchange of mHealth data between apps in a very efficient way. With only a few exceptions, Pharma apps do not generally make use of third party health and/or fitness data. For medical condition management apps (Pharma app portfolio share = 20%), this will be a must in the future.

Strengthen Android app presence and make use of cross-platform app development tools: Today only 45% of the leading Pharma companies’ apps are available both on iOS and Android. Admittedly, it might not make sense to develop any of the already existing “long-tail” apps for Android, but future app developments should target both platforms right from the beginning. Otherwise, large market segments will not be reached. A multi-platform app development

7 API: Application Programming Interface


approach should always include the usage of cross-platform app development tools to limit development cost and time. See “Cross-Platform Tool Benchmarking 2014 Report- find the right tool for any app project8". Given that such tools offer significant time savings, they should constitute an important building block of any new app development project.

Become truly global: Only half (51%) of the Pharma app publishing entities launch their apps in more than 3 countries. The other half is active in just 1-3 countries. This means that a great share of apps are not available for download globally, which limits the chances of having a significant impact on the app market. One of the major advantages of the app ecosystem Apple has created in 2008 was that reach out to a global audience. Top Pharma app publishers do not make use of this opportunity.

Align app publishing governance and competencies: There might be internal or legal reasons for having up to 17 different publisher entities, but in order to become a major player in the mHealth app economy this is certainly not the best governance model. App ideation, concept writing, selection of the best agency, app development, update management and marketing have become demanding tasks which require expert skills. Pharma companies compete with 100% dedicated mHealth app publishers who align all their competencies to build and market mHealth apps best in class. This is not the case within most of the Pharma companies. This creates a significant competitive disadvantage Pharma needs to face. In order to compete in the Health app market Pharma companies must align their app competencies globally. This would be also the prerequisite for all the options mentioned above.

Besides the need for improving their current mHealth app publishing business, Pharma companies should

start a discussion around its role in the mHealth app publishing i.e. which steps suit best to their

competencies and reflects market dynamics.

The above analysis shows that since the start of the app market, Pharma companies have not yet proven

to be successful mHealth app publishers. They will be challenged to become better in selecting the right

app ideas, designing the business models, making better reuse of existing concepts and codes or in

leveraging existing marketing channels to promote their apps. However, it is not clear whether it will be

enough to compete against the hundred thousands of mHealth app developers who are 100% dedicated

or tech giants like Apple, Google or Samsung that have recently entered into the mHealth app market.

Would it be a good investment to develop and publish the next 700+ apps the next five years? Which

other role/s could a Pharma company play in the app economy? There are many potential roles and the

following ones should be used as a starting point for the discussion within a company.

1. App publisher: This is the current role and continuing to play that role would require Pharma to restructure its current mHealth business.

2. Investor: For some companies it might be more appropriate to open up a fund which invests money and other resources into promising or already successful mHealth apps. This role would require an excellent screening and evaluation capability. VCs and incubators that concentrate on apps are able to work off a pipeline of 1,000 mHealth apps per year.

3. App aggregator (app store): Lack of visibility in the congested app stores creates a need for specialized mHealth app stores. Pharma companies could pre-select mHealth apps which fit to their core products or fulfil current market demands. It does not matter which compliance app is downloaded as long it increases the adherence of the users and allows more users to find the right app for their needs. The role of a Pharma company would be to manage and promote the app store among app developers as well as to HCPs and patients.

4. Data provider /API manager: There will be hundreds of mHealth apps capturing millions of vital data metrics from their users every day. Most of it will be stored on “walled garden” servers with no link to the healthcare systems in doctor’s offices or hospitals. There are already companies

8 The „Cross Platform Tool Benchmarking 2014 Report“ is available on www.research2guidance.com


which try to bridge the gap between the app economy and the healthcare system, but the question is if a Pharma company would be able to jump into this very dynamic market with all their financial strength and the immense value it could extract for itself from the data analysis to create better products.

A prerequisite for all of the last three roles is an excellent link into the mHealth app developer community

and a good understanding of their needs and concerns. Some of the Pharma companies have started to

do occasional app developer events like Hackathons or mHealth competitions, but this is not enough to fill

the pipeline of e.g. 1,000 apps per year, to get e.g. the 20 best mHealth apps for cancer diagnosis, asthma

management or eyesight testing onto the own app store or understand what value app developers would

expect from allowing the mHealth data aggregator to access their data.

Pharma companies need to treat app developers as their customers who must to be understood,

segmented and managed the same way Pharma companies do that today with e.g. doctors.

What this all means is that before going forward in the same way as the last five years, Pharma companies

should rethink their mHealth app strategy. Otherwise they will remain an industry with low impact on the

mHealth app market. This is not a serious threat to their core business today, but in five years it might be.

Research2guidance


8. PHARMA APP CATALOGUE (LIST OF APPS BY COMPANY AND PLATFORM)

Company Platform Title Category

Abbott iOS Abbott Animal Health I.V. Fluid Volume

Calculator

Pet care

Abbott iOS Abbott Animal Health I.V. Fluid Volume

Calculator for iPad

Pet care

Abbott Android Abbott Animal Health IV Fluids Pet care

Abbott iOS Abbott FISH Chromosome Search Medical reference

Abbott iOS Abbott HE4 Ovarian Risk Calculator Medical calculator

Abbott iOS Abbott IOL Vision Simulator Private education

Abbott iOS Abbott Nutrition Product Guide Medical reference

Abbott Android Body-for-LIFE Health tracking

Abbott iOS CED Dokumentation und Tipps Medical information

Abbott Android CED Dokumentation und Tipps Medical information

Abbott iOS Clearance - GFR Calculator Medical calculator

Abbott iOS e-Diagnostics Medical reference

Abbott Android e-Diagnostics Medical reference

Abbott iOS eHaq Medical condition

management

Abbott iOS Endofacts: Road to Relief Private education

Abbott iOS Happy Alimi Medical condition

management

Abbott Android Happy Alimi Medical condition

management

Abbott iOS HCV Life Cycle by AbbVie Medical reference

Abbott iOS Knowledge Genie Medical education

Abbott iOS NeproCare Medical reference

Abbott Android NeproCare Medical reference

Abbott iOS NutriCare Calculator in TI Medical reference

Abbott Android Product Guide Medical reference



Abbott iOS Psoriasis Anti-TNF Atlası Medical reference

Abbott iOS Psoriasis Skin Diary Medical condition

management

Abbott iOS Renal Chart Medical calculator

Abbott Android Renal Chart Medical calculator

Abbott iOS Similac Baby Journal Baby

Abbott Android Similac Baby Journal Baby

Abbott Android Similac Baby Journal - Canada Baby

Abbott iOS Similac Baby Journal for Canada Baby

Abbott Android Similac Mom Baby Journal Baby

Abbott iOS Similac Mom Baby Journal Baby

Abbott iOS Similac Wee Gallery Baby

Abbott iOS Similac Дневник малыша Baby

Abbott iOS Sincrohnizando Diagnostic tool

Abbott Android Sincrohnizando Diagnostic tool

Abbott iOS STARLIMS Medical reference

Abbott Android STARLIMS Medical reference

Abbott iOS Thyro App Medical information

Abbott Android THyro App Medical information

Abbott iOS Vascular Videos: Private Education Private education

Abbott iOS Women’s Vascular Health: Private

Education

Private education

Abbott iOS ZemPro Medical calculator

Astra iOS AKS’yi ANLAMAK Medical information

Astra Android ASK Medical Medical reference

Astra iOS AsthmaCrise Medical condition

management

Astra Android Asthmacrise Medical condition

management

Astra Android AstraZeneca - Interactive SCOR Diagnostic tool

Astra iOS AstraZeneca Calculadora Riesgo CV Diagnostic tool



Astra iOS AstraZeneca Investor Relations Medical and health news

Astra iOS Atouscore Medical reference

Astra Android AtouScore Medical reference

Astra iOS Atypical MoA Medical reference

Astra iOS BCVS 2014 Conference Notes Other

Astra iOS Beräkna risk för fatal hjärta-

kärlhändelse

Medical reference

Astra Android Beräkna risk för hjärta & kärl Medical reference

Astra iOS Beregn risikoen for fatal-

kardiovaskulær hændelse

Medical reference

Astra Android Bon Pour Mon Coeur Medical information

Astra iOS Bon Pour Mon Coeur Medical information

Astra iOS BRILIQUE™ E-Book Medical reference

Astra iOS Bydureon Medical information

Astra Android Bydureon DK Medical information

Astra Android Bydureon FI Medical information

Astra Android Bydureon SE Medical information

Astra Android Calculadora Riesgo CV Medical reference

Astra iOS Comprendre Le SCA Private education

Astra iOS Crusade Bleeding Score Medical reference

Astra Android Dia+ Medical condition

management

Astra iOS Diagnostics Difficiles en pneumologie Diagnostic tool

Astra iOS DIRETO Medical and health news

Astra iOS Epdwallet Medical work management

Astra Android FarmaServicios Medical information

Astra iOS Framingham Diagnostic tool

Astra iOS GRACE ACS Risk Calculator Medical reference

Astra Android Hellenic Score Medical information

Astra iOS Hjärt-medicinska förkortningar Medical reference

Astra Android Hjärt-medicinska förkortningar Medical reference



Astra iOS Hjerte-medicinske forkortelser Medical reference

Astra iOS Longmagazine Medical information

Astra iOS Longpas Medical condition

management

Astra iOS Lungenchecker Medical information

Astra iOS Migrain-e Headache

Astra iOS Migraine & Aura Medical reference

Astra iOS Migrain-e CH Headache

Astra iOS NRLS eMag Medical and health news

Astra iOS PainCatcher Pain management

Astra Android PainCatcher Pain management

Astra iOS Prostate Assistant Medical condition

management

Astra Android QRx MÉDICALES Medical reference

Astra iOS Simulador Virtual en Salud Mental Medical reference

Astra iOS Symbicort AR Private education

Astra iOS Ticagrelor / Brilique handboek Medical reference

Astra Android Ticagrelor / Brilique handboek Medical reference

Astra iOS TNM Pocket Medical reference

Astra iOS Trivia diabetes editie Medical reference

Astra iOS Trivia hart- en vateneditie Health game

Astra iOS Trivia psychiatrie editie Medical reference

Astra iOS Turbuhaler Augmented Reality Medical information

Astra iOS Understanding ACS Medical and health news

Astra iOS Understanding Acute Coronary

Syndrome (ACS)

Private education

Astra iOS Virtual Coro Medical reference

Astra Android Virtual Coro Medical reference

Bayer

HealthCare

iOS Andromecum Medical reference

Bayer Android Andromecum Medical reference



HealthCare

Bayer

HealthCare

iOS Antykoncepcja dlugoterminowa Medical reference

Bayer

HealthCare

iOS ART Score Medical reference

Bayer

HealthCare

Android ART Score Medical reference

Bayer

HealthCare

iOS Aşkı Şansa Bırakma Fertility

Bayer

HealthCare

iOS Aşkı Şansa Bırakma - iPad Fertility

Bayer

HealthCare

iOS Baycox Medical calculator

Bayer

HealthCare

Android Baycox Medical calculator

Bayer

HealthCare

Android Bayer Agrar Wetter Austria Other

Bayer

HealthCare

Android Bayer Para Você Medical condition

management

Bayer

HealthCare

iOS Bayer Para Você Medical condition

management

Bayer

HealthCare

iOS Bayer Para Você para iPad Medical condition

management

Bayer

HealthCare

Android BayerAgrar TV Other

Bayer

HealthCare

Android BayerBBS Other

Bayer

HealthCare

iOS Baytril ® 100 Dosing Calculator Pet care

Bayer

HealthCare

iOS Baytril Solução – Cálculo Dosagens Pet care

Bayer

HealthCare

Android Baytril Solução – Dosagens Pet care

Bayer

HealthCare

Android BBCH-Stadien Other

Bayer iOS BBSBayer Pet care



HealthCare

Bayer

HealthCare

Android BCS Cowdition Pet care

Bayer

HealthCare

iOS Bepanthol Futura Mama Pregnancy

Bayer

HealthCare

Android Bepanthol Futura Mamá Pregnancy

Bayer

HealthCare

iOS Breast MRI Medical reference

Bayer

HealthCare

iOS Calculadora Escore ART Medical calculator

Bayer

HealthCare

Android Calculadora Escore ART Medical calculator

Bayer

HealthCare

iOS Calculadora Síndrome Mão Pé Medical reference

Bayer

HealthCare

Android Carnet antiparasitaire Pet care

Bayer

HealthCare

iOS Carnet antiparasitaire de mon animal Pet care

Bayer

HealthCare

iOS Consenso ACO Medical reference

Bayer

HealthCare

Android Consenso ACO Medical reference

Bayer

HealthCare

Android CRC tools Medical reference

Bayer

HealthCare

iOS CRC Tools Medical reference

Bayer

HealthCare

iOS Ederal Medical calculator

Bayer

HealthCare

Android Ederal Medical calculator

Bayer

HealthCare

Android FactorTrack Espana Medical condition

management

Bayer

HealthCare

Android FactorTrack Italia Medical condition

management

Bayer iOS FactorTrack™ Medical condition



HealthCare management

Bayer

HealthCare

iOS FactorTrack™ Medical condition

management

Bayer

HealthCare

iOS FactorTrack™ (JP) Medical condition

management

Bayer

HealthCare

Android FactorTrack™ (JP) Medical condition

management

Bayer

HealthCare

iOS FactorTrack™ (NL) Medical condition

management

Bayer

HealthCare

Android FQApp Medical reference

Bayer

HealthCare

iOS Futura Mamãe Pregnancy

Bayer

HealthCare

iOS Gestação Semana a Semana Pregnancy

Bayer

HealthCare

iOS GlicoCare Diabetes management

Bayer

HealthCare

Android Glicocare Diabetes management

Bayer

HealthCare

iOS GlicoCare Para iPad Diabetes management

Bayer

HealthCare

Android Happy Feet Other

Bayer

HealthCare

Android Heart Health Score Medical reference

Bayer

HealthCare

iOS HemoFile® Medical condition

management

Bayer

HealthCare

iOS HemoFit Medical information

Bayer

HealthCare

iOS HemoSport Medical condition

management

Bayer

HealthCare

iOS Hora da Pílula Medication reminder

Bayer

HealthCare

Android Hora da Pílula para Android Medication reminder

Bayer iOS Hora da Pílula PT Medication reminder



HealthCare

Bayer

HealthCare

iOS iBETAplus™ (BR) Medical condition

management

Bayer

HealthCare

iOS Interactive RHC Tool Medical reference

Bayer

HealthCare

Android Jungle For Pets Pet care

Bayer

HealthCare

iOS Jungle For Pets: parasite protection for

your pet

Pet care

Bayer

HealthCare

Android Krankheiten Medical information

Bayer

HealthCare

iOS LeishApp Pet care

Bayer

HealthCare

Android LeishApp Pet care

Bayer

HealthCare

iOS Meu Diário Mensal Fertility

Bayer

HealthCare

iOS mijnMDD Medical condition

management

Bayer

HealthCare

Android mijnMDD Medical condition

management

Bayer

HealthCare

iOS Modern Spiral Medical reference

Bayer

HealthCare

iOS Monthly Me Fertility

Bayer

HealthCare

iOS Monthly Me Fertility

Bayer

HealthCare

iOS My iPill - contraception reminder Medication reminder

Bayer

HealthCare

iOS myBETAapp™ (ES) Medical condition

management

Bayer

HealthCare

iOS myBETAapp™ (TR) Medical condition

management

Bayer

HealthCare

iOS Neuroscore EDSS Medical calculator

Bayer iOS PH MAP Other



HealthCare

Bayer

HealthCare

Android PH MAP Other

Bayer

HealthCare

Android Pill Reminder Medication reminder

Bayer

HealthCare

iOS Pill Reminder+ Medication reminder

Bayer

HealthCare

Android Pillenalarm Medication reminder

Bayer

HealthCare

iOS Rabon Calculator Pet care

Bayer

HealthCare

Android Rabon Calculator Pet care

Bayer

HealthCare

Android Schädlinge Other

Bayer

HealthCare

iOS Skin Peace Medical reference

Bayer

HealthCare

Android Skin Peace Medical reference

Bayer

HealthCare

iOS Tansiyon GITSin Medical reference

Bayer

HealthCare

iOS Target Vet - Guia Antimicrobiano Pet care

Bayer

HealthCare

Android Target Vet-Guia Antimicrobiano Pet care

Bayer

HealthCare

iOS TestoCheck (ES) Health tracking

Bayer

HealthCare

Android Ungräser Other

Bayer

HealthCare

Android Universo Médico Medical reference

Bayer

HealthCare

iOS Universo Médico Medical reference

Bayer

HealthCare

iOS Universo Médico Para iPad Medical reference

Bayer Android Unkräuter Other



HealthCare

Bayer

HealthCare

iOS Whole Body MRI Medical reference

Bayer

HealthCare

Android Whole Body MRI Medical reference

Bayer

HealthCare

Android Клайра App Medication reminder

Bayer

HealthCare

iOS かた丸くん忍法ナビ Other

Bayer

HealthCare

Android かた丸くん忍法ナビ Other

Bayer

HealthCare

Android 三高小幫手 Medical condition

management

Bristol Myers iOS BMS Melanoma Medical condition

management

Bristol Myers iOS CkMt AE Mgmt Medical reference

Bristol Myers Android CkMt AE Mgmt Medical reference

Bristol Myers iOS Continuum of Care Medical information

Bristol Myers iOS iEcho Medical reference

Bristol Myers iOS iEchoHD Medical reference

Bristol Myers Android Mobile Merch Other

Bristol Myers iOS Mobile Merch Other

Bristol Myers iOS wellB Medical condition

management

Bristol Myers Android wellB Medical condition

management

Bristol Myers iOS 適正使用チェッカー Diagnostic tool

Johnson &

Johnson

iOS *Acuminder Eyesight

Johnson &

Johnson

iOS 21日口腔挑戰 Health game

Johnson &

Johnson

Android Acuminder Eyesight

Johnson & iOS Acuminder FR Eyesight



Johnson

Johnson &

Johnson

Android Acuminder FR Eyesight

Johnson &

Johnson

iOS ACUVUE® DEFINE Beauty

Johnson &

Johnson

iOS ACUVUE® ET VOUS Eyesight

Johnson &

Johnson

Android ACUVUE® ET VOUS Eyesight

Johnson &

Johnson

Android ACUVUE® LENSPAL™ Eyesight

Johnson &

Johnson

iOS ACUVUE® LENSPAL™ Eyesight

Johnson &

Johnson

iOS ACUVUE® MOIST® Eyesight

Johnson &

Johnson

iOS ACUVUE® Starter Schweiz Eyesight

Johnson &

Johnson

iOS ACUVUE® TEYEMER™ Eyesight

Johnson &

Johnson

Android ACUVUE® TEYEMER™ Eyesight

Johnson &

Johnson

iOS BAND-AID® Brand MAGIC VISION™ Other

Johnson &

Johnson

iOS BAND-AID® BRAND MAGIC VISION™

APP STARRING NICKELODEON’S

TEENAGE MUTANT NINJA TURTLES

Other

Johnson &

Johnson

iOS BAND-AID® Magic Vision Starring

Disney's® the Muppets

Other

Johnson &

Johnson

Android Bursting Beads Other

Johnson &

Johnson

Android Calculadora de Saúde Medical information

Johnson &

Johnson

iOS Calculadora de Saúde Medical information

Johnson &

Johnson

Android Clean & Clear Best Friends Other



Johnson &

Johnson

iOS Digital Health Scorecard Medical information

Johnson &

Johnson

Android Digital Health Scorecard Medical information

Johnson &

Johnson

iOS Donate a Photo Other

Johnson &

Johnson

Android Donate a Photo Other

Johnson &

Johnson

iOS Eczema Care Medical condition

management

Johnson &

Johnson

iOS Eye Education Medical reference

Johnson &

Johnson

Android Eye Education Medical reference

Johnson &

Johnson

iOS Happy Nurse™ Health game

Johnson &

Johnson

iOS IMODIUM Toilet Tracker Other

Johnson &

Johnson

Android Imodium Toilet Tracker Other

Johnson &

Johnson

iOS J&J Investor Other

Johnson &

Johnson

Android JBaby Grandparents Frame Other

Johnson &

Johnson

iOS JOHNSON & JOHNSON WOUND CARE

RESOURCE™ App

Medical information

Johnson &

Johnson

iOS JOHNSON'S® Baby BEDTIME™ Sleep Baby

Johnson &

Johnson

iOS LENSPAL ME Eyesight

Johnson &

Johnson

iOS LENSPAL ME ARABIC Eyesight

Johnson &

Johnson

iOS LENSPAL™ Eyesight

Johnson &

Johnson

Android LENSPAL™ Eyesight



Johnson &

Johnson

iOS LENSPAL™ Deutschland Eyesight

Johnson &

Johnson

Android LENSPAL™ Deutschland Eyesight

Johnson &

Johnson

iOS Listerine 21 Day Challenge Other

Johnson &

Johnson

Android Livocab® direkt - Pollen-Alarm Medical condition

management

Johnson &

Johnson

iOS Livocab® direkt Pollen-Alarm-App Medical condition

management

Johnson &

Johnson

Android My Baby Diary Baby

Johnson &

Johnson

iOS Nicorette ActiveStop Addiction

Johnson &

Johnson

Android Regaine Hair Other

Johnson &

Johnson

iOS ROGAINE® Other

Johnson &

Johnson

Android Spirit Cam Other

Johnson &

Johnson

iOS Summer Hunt Other

Johnson &

Johnson

iOS SunStop Medical information

Johnson &

Johnson

Android SunStop by Lubriderm Medical information

Johnson &

Johnson

iOS The REACTINE® Pollen Forecast Medical condition

management

Johnson &

Johnson

iOS Whipple术 Medical reference

Johnson &

Johnson

iOS 二尖瓣修复术 Medical reference

Johnson &

Johnson

iOS 二尖瓣置换术 Medical reference

Johnson &

Johnson

iOS 強生嬰兒 - bb成長小百科 Pregnancy



Johnson &

Johnson

iOS 领医迈 for iPhone Medical education

Johnson &

Johnson

iOS 领医迈HD Medical reference

GlaxoSmithKline iOS 918 ClinKit Medical reference

GlaxoSmithKline Android 918 ClinKit Medical reference

GlaxoSmithKline Android Aquafresh Brush Time Child`s health

GlaxoSmithKline iOS Aquafresh Brush Time Child`s health

GlaxoSmithKline Android Aquafresh Brush Time - SA Child`s health

GlaxoSmithKline Android Aquafresh Brush Time GER Child`s health

GlaxoSmithKline iOS Aquafresh Brush Time South Africa Child`s health

GlaxoSmithKline Android Aquafresh Brush Time USA Child`s health

GlaxoSmithKline iOS Aquafresh Brush Time USA Child`s health

GlaxoSmithKline iOS Aquafresh Čas čistenia Child`s health

GlaxoSmithKline Android Aquafresh Nurdle Time Child`s health

GlaxoSmithKline iOS Aquafresh Nurdle Time Child`s health

GlaxoSmithKline iOS Aquafresh Време за зъбки Child`s health

GlaxoSmithKline iOS ARIA ClinKit Medical reference

GlaxoSmithKline Android ARIA ClinKit Medical reference

GlaxoSmithKline Android AsthmaApp Medical condition

management

GlaxoSmithKline iOS Atmosfer Solunum Platformu Medical reference

GlaxoSmithKline Android Augmentin® Dosier App Medical reference

GlaxoSmithKline iOS Augmentin® Dosier App Medical reference

GlaxoSmithKline iOS Basic Periodontal Examination App Medical reference

GlaxoSmithKline Android BOOST Your Winnings Other

GlaxoSmithKline iOS Children's Panadol App Child`s health

GlaxoSmithKline iOS COPD App Diagnostic tool

GlaxoSmithKline Android COPD App Diagnostic tool

GlaxoSmithKline Android Czyste Ząbki z Aquafresh® Child`s health

GlaxoSmithKline iOS Czyste Ząbki z Aquafresh® Child`s health



GlaxoSmithKline iOS Diabetes HealthMate Diabetes management

GlaxoSmithKline iOS e-CAT EHR-D

GlaxoSmithKline Android eDott Medical and health news

GlaxoSmithKline Android ÉnAsztmám Medical condition

management

GlaxoSmithKline iOS ÉnAsztmám Medical condition

management

GlaxoSmithKline iOS Eppy Medical condition

management

GlaxoSmithKline Android FACE THE DAY™ Health tracking

GlaxoSmithKline Android Fit for Travel Other

GlaxoSmithKline Android Fit2Travel Medical information

GlaxoSmithKline Android GRIT Medical reference

GlaxoSmithKline iOS GRIT - Genotypic Resistance

Interpretation Tool

Medical reference

GlaxoSmithKline iOS GSK 희망 알림 BC Medical information

GlaxoSmithKline Android GSK 희망 알림 BC Medical information

GlaxoSmithKline iOS GSKお薬情報 Medical condition

management

GlaxoSmithKline iOS HepBaware Medical information

GlaxoSmithKline Android HepBaware Medical information

GlaxoSmithKline iOS ITPダイアリー Medical information

GlaxoSmithKline Android ITPダイアリー Medical information

GlaxoSmithKline Android Lo Score di Wells Medical information

GlaxoSmithKline iOS Macleans Nurdle Time Child`s health

GlaxoSmithKline iOS MaxiApp Other

GlaxoSmithKline Android Mi Asma Medical condition

management

GlaxoSmithKline iOS Mi Asma Medical condition

management

GlaxoSmithKline Android MijnAstma Medical condition

management



GlaxoSmithKline iOS MijnAstma Medical condition

management

GlaxoSmithKline Android MinAsthma Medical condition

management

GlaxoSmithKline iOS MinAstma Medical condition

management

GlaxoSmithKline Android Mit syge barn Child`s health

GlaxoSmithKline iOS Mit syge barn Child`s health

GlaxoSmithKline Android MojaAstma Medical condition

management

GlaxoSmithKline iOS MojaAstma Medical condition

management

GlaxoSmithKline Android Mon Asthme Medical condition

management

GlaxoSmithKline iOS Mon Asthme Medical condition

management

GlaxoSmithKline iOS My Asthma Denmark Medical condition

management

GlaxoSmithKline iOS My Diary Medical condition

management

GlaxoSmithKline Android My Diary Medical condition

management

GlaxoSmithKline Android My Lupus Log Medical condition

management

GlaxoSmithKline iOS My PAH-tner Health tracking

GlaxoSmithKline Android my PAH-tner Health tracking

GlaxoSmithKline iOS MyAsthma Medical condition

management

GlaxoSmithKline Android MyAsthma (Australia) Medical condition

management

GlaxoSmithKline iOS MyAsthma Aus Medical condition

management

GlaxoSmithKline iOS MyAsthma Canada Medical condition

management

GlaxoSmithKline Android MyAsthma Canada Medical condition



management

GlaxoSmithKline Android MyAsthma Denmark Medical condition

management

GlaxoSmithKline Android MyAsthma Finland Medical condition

management

GlaxoSmithKline Android MyAsthma India Medical condition

management

GlaxoSmithKline iOS MyAsthma India Medical condition

management

GlaxoSmithKline iOS MyAsthma UK Medical condition

management

GlaxoSmithKline Android MyAsthma UK Medical condition

management

GlaxoSmithKline iOS Neumo Medical reference

GlaxoSmithKline iOS NO MAS COBRAS Other

GlaxoSmithKline Android NO MAS COBRAS Other

GlaxoSmithKline Android Nurdle Time Child`s health

GlaxoSmithKline iOS Odol Čas čištění Child`s health

GlaxoSmithKline iOS Odol-med3 Putzzeit Child`s health

GlaxoSmithKline Android Periază-te cu Bulgăraş! Child`s health

GlaxoSmithKline iOS Periază-te cu Bulgăraş! Child`s health

GlaxoSmithKline iOS Piri Pollen Medical condition

management

GlaxoSmithKline iOS PneumoDoc Medical reference

GlaxoSmithKline iOS SLEDAI (SELENA Modification) Medical reference

GlaxoSmithKline Android Tijd voor tandenpoetsen met Aq Child`s health

GlaxoSmithKline iOS Tijd voor tandenpoetsen met

Aquafresh

Child`s health

GlaxoSmithKline Android Vaccine App Medical information

GlaxoSmithKline iOS Vaccine App Medical information

GlaxoSmithKline iOS Vaccinkortet Medical condition

management

GlaxoSmithKline Android Vaccinkortet Medical condition



management

GlaxoSmithKline iOS Vergissmeinnicht Child`s health

GlaxoSmithKline Android ViajarSano Medical information

GlaxoSmithKline iOS ViajarSano Medical information

GlaxoSmithKline iOS Viaje Prevenido Medical information

GlaxoSmithKline Android Viaje Prevenido Medical information

GlaxoSmithKline iOS WalkAlong Fitness tracking

GlaxoSmithKline Android Никвитин Addiction

GlaxoSmithKline iOS Час чистити зубки з Аквафреш Child`s health

GlaxoSmithKline iOS ぜんそくアプリ Medical condition

management

GlaxoSmithKline iOS ぜんそくよくな～れ! Child`s health

GlaxoSmithKline Android 飛び出す！吸入器の使い方 Medical information

Merck iOS Advancing the Journey of the Molecule

- Merck Millipore

Reference

Merck iOS dialogMS Medical

Merck Android dialogMS Medical

Merck iOS Elix Business

Merck Android EMD PTE Education

Merck iOS FertApp per iPhone Medical

Merck Android Glucophage SR & Me Medical

Merck iOS Glucophage SR and Me Medical

Merck iOS Gonal-f Medical

Merck Android Gonal-f Medical

Merck iOS iEffect Lifestyle

Merck iOS Merck Millipore ChromBook Business

Merck iOS Merck Millipore Interactive Histone

Modificatio...

Reference

Merck iOS Merck Millipore Sterile Selector App Reference

Merck iOS Merck Millistak+ Filter Hardware Reference



Interactive Guide

Merck iOS Merck PSE Education

Merck iOS Merck PTE HD Education

Merck Android Merck PTE HD Education

Merck iOS Merck Viresolve Pro+ Magnus Holder Reference

Merck Android Meu diário em diabetes Medical

Merck iOS Millex Filter Finder Reference

Merck iOS Millex Filter Finder HD Reference

Merck iOS Milli-Q Business

Merck iOS MSdialog Medical

Merck Android MSdialog Medical

Merck Android Piriri App Medical

MSD iOS Alerta Anel Medical

MSD Android Alerta Anel Medical

MSD Android Alerta Pílula Medical

MSD iOS Alerta Pílula Medical

MSD iOS Algoritmo CVM Medical

MSD Android Algoritmo CVM Medical

MSD iOS Allergia Radar Healthcare & Fitness

MSD Android Allergia Radar Health And Fitness

MSD iOS Calcolatore del dosaggio

Peginterferone

Medical

MSD iOS Calcolatore Della Funzionalità Renale Medical

MSD Android Calcolatore FunzionalitàRenale Medical

MSD Android Calculadoras HCV Medical

MSD iOS Calculadoras HCV Medical

MSD iOS Candida Risk Calc Medical

MSD iOS Cardio Sound Medical

MSD Android Cardio Sound Medical

MSD iOS ChemoScore Medical



MSD Android ChemoScore Medical

MSD iOS C-Timer Medical

MSD Android C-Timer Medical

MSD iOS CVM 360 Medical

MSD iOS DAS28 Medical

MSD iOS DiabetoPartner Medical

MSD Android DiabetoPartner Health And Fitness

MSD iOS Fertilistim Medical

MSD Android Fertilistim Medical

MSD Android Fertility Patient Support Medical

MSD iOS Glaucoma SIM Medical

MSD iOS Glaucoma SIM Aus Medical

MSD iOS Glaucomanet Medical

MSD iOS Glaucome Info Medical

MSD iOS iChemioDiary Medical

MSD iOS iChemoDiary Medical

MSD Android iChemoDiary Medical

MSD iOS Il Diario del colesterolo Medical

MSD Android Il Diario del Colesterolo Medical

MSD iOS IntroClick Medical

MSD Android Mein positives Tagebuch Health And Fitness

MSD iOS Merck Sharp & Dohme FCU Finance

MSD Android Mon Journal Positif Medical

MSD iOS Mon Journal Positif pour smartphone Medical

MSD iOS Mon journal positif pour tablette Medical

MSD iOS MSD Fertility Treatment Medical

MSD iOS MSD Sketchbook Medical

MSD Android My Health Matters Medical

MSD iOS My Health Matters United Kingdom Medical

MSD iOS ONCOLOGIA: Controle de náuseas e Medical



vômitos

MSD Android ONCOLOGIA: diário do paciente Medical

MSD Android ONCOLOGIA: Náuseas e Vômitos Health And Fitness

MSD iOS Pegatron Dosage Calculator Medical

MSD iOS Polipi Nasali Medical

MSD Android Polipi Nasali Medical

MSD iOS Puregon Patient Support Medical

MSD Android Puregon Reminder Medical

MSD iOS QUIMIOTERAPIA: acompanhamento

do tratamento

Medical

MSD iOS Ramadan, Diabetes and Me App Medical

MSD iOS Regolo Contraccettivo Medical

MSD Android Regolo contraccettivo Medical

MSD iOS Reumatrix Medical

MSD Android ReuMATRIX Health And Fitness

MSD iOS RingTimer ch Medical

MSD Android RingTimer ch Medical

MSD iOS Rischio CV Medical

MSD iOS Scale di valutazione del dolore Medical

MSD Android SCALE SVD Medical

MSD iOS Score in epatologia Medical

MSD Android Score in epatologia Medical

MSD iOS Sugammadex Medical

MSD Android Sugammadex Medical

MSD Android TUP - Trouver Un Préservatif Medical

MSD iOS TUP - Trouver Un Préservatif Healthcare & Fitness

MSD iOS Victrelis Reminder Medical

MSD iOS Z-Timer Medical

MSD Android Z-Timer Medical

Novartis iOS 2AlertU D-D communication



Novartis iOS Afinitor® Medical reference

Novartis Android Afinitor® Medical reference

Novartis iOS Assess the Risk: GIST Medical reference

Novartis iOS CF360 Health tracking

Novartis iOS CFpal ™ Health tracking

Novartis Android CFpal ™ Health tracking

Novartis iOS Clinical Trial Seek Medical reference

Novartis iOS CML-Therapiemanager Medical work management

Novartis iOS CML-Therapiemanager für iPhone Medical work management

Novartis iOS CML服薬手帳 Medical condition

management

Novartis Android CML服薬手帳 Medical condition

management

Novartis Android Coach Cardinal Diabetes management

Novartis iOS Day by Day Health tracking

Novartis iOS EvaluSkin Medical condition

management

Novartis iOS GIST Explorer Medical education

Novartis iOS GIST ROR Medical reference

Novartis iOS GIST再発リスク評価 Medical reference

Novartis Android Huisdier Vakantie App Pet care

Novartis iOS Huisdier Vakantie App Pet care

Novartis iOS IPSS Calculator International Medical calculator

Novartis Android Lauffeuer Fitness tracking

Novartis iOS Lauffeuer Fitness tracking

Novartis iOS M1: Pulmón Virtual Medical education

Novartis iOS M2: Pulmón Virtual – EPOC Medical education

Novartis iOS M3: Pulmón Virtual – Asma Bronquial Medical education

Novartis Android MAImoris-e Medical condition

management

Novartis iOS Marley’s World Other



Novartis iOS Multiple Esclerosis Medical condition

management

Novartis iOS My Acro Manager Medical condition

management

Novartis iOS My Migraine Triggers Health tracking

Novartis Android My Migraine Triggers™ Headache

Novartis iOS MyAcroManager Medical condition

management

Novartis Android MyCongress Other

Novartis iOS myGIST Companion Medical condition

management

Novartis iOS MyNet Manager Medical condition

management

Novartis iOS NesselApp Medical condition

management

Novartis iOS Nicotinell Unfiltered Addiction

Novartis iOS Novartis ARena Other

Novartis iOS Novartis Investor and Media Other

Novartis iOS Novartis Med Info Medical reference

Novartis Android Novartis Medical Information Medical and health news

Novartis iOS Novartis Pharma Canada Medical

Information

Medical reference

Novartis iOS Novartis Türkiye Other

Novartis iOS NovartisiMag Medical and health news

Novartis Android Ongoing Trials Medical reference

Novartis iOS PatchMate Health tracking

Novartis iOS PatientTrack Medication reminder

Novartis iOS Podhaler™Pro™ Health tracking

Novartis Android Rauchstopp Addiction

Novartis Android Retina Base Medical reference

Novartis Android Reward Motivational

Novartis Android SEP-Agenda Medical condition

management



Novartis iOS SibA – Simulation bei

Augenerkrankungen

Eyesight

Novartis Android SibA – Visussimulation Medical reference

Novartis iOS Sickle Cell Disease Resource Locator Products and/or services

finder

Novartis iOS Sickle Cell Iron Invaders Health game

Novartis Android Stopsupporter Addiction

Novartis iOS Stopsupporter Addiction

Novartis iOS TSC Central Health tracking

Novartis iOS TSC Diagnostic Tool Diagnostic tool

Novartis iOS TSC鉴别诊断工具 Diagnostic tool

Novartis iOS ViaOpta Nav Eyesight

Novartis iOS ViaOpta Simulator Eyesight

Novartis iOS ViaOptaDaily Eyesight

Novartis iOS WheresFlu Health tracking

Novartis iOS ネイルと健康 Beauty

Novartis iOS ブリーズヘラー吸入指導アプリ Medical information

Novartis Android 스마트 닥터 Diabetes management

Novartis iOS 投与量計算アプリ Medical education

Pfizer iOS AcroTracker Medical condition

management

Pfizer Android Acrotracker Medical condition

management

Pfizer iOS AcroTracker Canada Medical condition

management

Pfizer iOS BeneMobile Medical condition

management

Pfizer Android BeneMobile Medical condition

management

Pfizer iOS BMS/PFIZER Events Other

Pfizer iOS Calc4GENO Medical calculator

Pfizer iOS GENOTROPIN GoQuick® Medical calculator



Pfizer iOS Haemophilia Dosing Assistant Medical reference

Pfizer iOS Haempack Medical reference

Pfizer iOS Happy Eye Eyesight

Pfizer Android Happy Eye Eyesight

Pfizer iOS Healthy life navi Diet

Pfizer iOS HemMobile Medical condition

management

Pfizer Android HemMobile Medical condition

management

Pfizer iOS Joint Defenders Child`s health

Pfizer iOS Know Your Pain Pain management

Pfizer Android Mijn Enbrel Other

Pfizer Android Min Hovedpine Headache

Pfizer iOS Min Hovedpine Headache

Pfizer iOS My Pfizer Medical reference

Pfizer Android My Pfizer Medical reference

Pfizer iOS Pfizer Growth Tracker Child`s health

Pfizer iOS Pfizer Meds Medical condition

management

Pfizer Android Pfizer Meds Medical condition

management

Pfizer iOS Pfizer pfusion Medical condition

management

Pfizer iOS Pfizer Strive Medical condition

management

Pfizer iOS Plan Q Addiction

Pfizer Android Recipes2Go Tablet Recipe

Pfizer Android Resisto Medical reference

Pfizer Android S-26 Club My Baby & Me Baby

Pfizer iOS Signal Swipe Medical reference

Pfizer Android SleepHelp Sleep

Pfizer iOS SleepHelp Sleep



Pfizer iOS smidge 2.0 Health tracking

Pfizer iOS Up2You Medical condition

management

Pfizer iOS VaxiMate Child`s health

Pfizer Android Vaximate Child`s health

Pfizer Android Vaximum Child`s health

Pfizer iOS Vaximum Child`s health

Pfizer iOS Vitasprint Running Alarm Other

Pfizer Android 健康小秘書 Medical condition

management

Pfizer iOS 健康小秘書 Medical information

Pfizer iOS 医路同行 D-D communication

Pfizer Android 医路同行 D-D communication

Pfizer iOS 話戒就戒 Addiction

Pfizer Android 話戒就戒 Addiction

Pfizer iOS 辉瑞医谷 Medical reference

Pfizer Android 辉瑞医谷 Medical reference

Roche iOS 5 Minuten Sanduhr Other

Roche iOS Accu-Chek Spirit Combo Medical reference

Roche iOS Accu-Chek Spirit Combo (FR) Other

Roche iOS Accu-Chek Spirit Combo (NL) Other

Roche Android ACCU-CHEK® 360° Diabetes Mgmt. Diabetes management

Roche iOS AntiHER2 Medical calculator

Roche iOS CIRS App Medical reference

Roche iOS cobas p 312 Medical reference

Roche iOS EAs 2014 Medical condition

management

Roche iOS eGFR-Rechner Medical calculator

Roche iOS Fettarm kochen Recipe

Roche iOS GeriApp Diagnostic tool



Roche iOS HepC eGuide Medical reference

Roche iOS HepC eService Medication reminder

Roche iOS Index Hémato Diagnostic tool

Roche iOS Lung+ Pioneering Healthcare Relaxation

Roche iOS Nierenbewusst Kochen Recipe

Roche iOS Oncoscale Diagnostic tool

Roche iOS OnkoRoche Medical and health news

Roche iOS QT Oral Medical calculator

Roche iOS RoaApp Sverige Medical information

Roche iOS Roche Oncology Pipeline Medical reference

Roche iOS Roche4U Congres App Medical and health news

Roche iOS Sciencebooster KR Health game

Roche iOS Zdrowa+ Medical information

Sanofi iOS AFib Educator Patient education

Sanofi Android AFibEducator Patient education

Sanofi iOS ArthCoach (ES) Pain management

Sanofi Android ArthCoach (ES) Pain management

Sanofi iOS ArthMouv Pain management

Sanofi Android ArthMouv Pain management

Sanofi iOS Auvi-Q™ (epinephrine injection, USP)

Companion

Products and/or services

finder

Sanofi iOS BabyFoille Baby

Sanofi Android BabyFoille Baby

Sanofi iOS Bebé Mitosyl Baby

Sanofi iOS Bridging App Medical reference

Sanofi Android Bridging App Medical reference

Sanofi Android Calculadora riesgo CV Medical reference

Sanofi iOS Campus Sanofi Medical reference

Sanofi iOS Caution Calculator Medical information

Sanofi Android Chase the Class Champ Child`s health



Sanofi iOS Chase the Class Champ Child`s health

Sanofi Android CLX Caprini Medical reference

Sanofi iOS CLX Caprini Medical reference

Sanofi Android CLX Cesareas Medical reference

Sanofi iOS CLX Cesáreas Medical reference

Sanofi iOS CLX Dosis Medical reference

Sanofi Android CLX Dosis Medical reference

Sanofi Android Companion EHR-P

Sanofi iOS Diabeo Diabetes management

Sanofi Android Diabeo Diabetes management

Sanofi Android Diguan Game Health game

Sanofi iOS Diguan Game. Controla mejor tu

diabetes.

Health game

Sanofi Android Gaucherlife Medical information

Sanofi iOS GoMeals Diabetes management

Sanofi Android GoMeals Diabetes management

Sanofi iOS GoMealsHD Diabetes management

Sanofi iOS Hair Protect Health game

Sanofi iOS iBGStar mg/dL Diabetes Manager

Application

Diabetes Management

Sanofi iOS iBGStar mmol/L Diabetes Manager

Application

Diabetes management

Sanofi iOS iBGStar® Diabetes Manager Diabetes management

Sanofi iOS Inject App Medical condition

management

Sanofi Android Inject App Medical condition

management

Sanofi iOS KidneyAPPetite™ Health tracking

Sanofi iOS Knee 360º Medical education

Sanofi iOS LEMCHECK Medical condition

management

Sanofi Android LEMCHECK Medical condition



management

Sanofi iOS LOV Caprini Medical reference

Sanofi Android LOV Caprini Medical reference

Sanofi iOS LOV dosagem Medical calculator

Sanofi Android LOV Dosagem Medical calculator

Sanofi iOS LTApp Chronische Nierschade Diagnostic tool

Sanofi Android LTApp Chronische Nierschade Diagnostic tool

Sanofi iOS Mamãe Applicada Child`s health

Sanofi Android Mamãe Applicada Brasil Child`s health

Sanofi iOS Manuale Roversi Medical reference

Sanofi iOS Medical Services Medical reference

Sanofi iOS Medikidz explain Type One Diabetes Medical information

Sanofi Android Medikidz Type 1 Diabetes Medical information

Sanofi Android Meu Ciclo Medication reminder

Sanofi iOS Meu Ciclo Medication reminder

Sanofi iOS Mission Phosphore Medical information

Sanofi Android Mission Phosphore Medical information

Sanofi iOS Mommy’s Book Kenya Child`s health

Sanofi iOS Mommy's Book India Child`s health

Sanofi Android MommysBook India Child`s health

Sanofi iOS Mon Glucocompteur Diabetes management

Sanofi Android Mon Glucocompteur Diabetes management

Sanofi iOS My Meetings - International Scientific

Meetings And Congresses

Medical work management

Sanofi Android MyMedico - der Gesundheitspass Medical information

Sanofi iOS MyMedico - der Gesundheitspass Medical information

Sanofi iOS MyRenagel Medical information

Sanofi Android MyRenagel Medical information

Sanofi iOS MyStarSMS Diabetes management

Sanofi iOS Oenobiol Activateur Minceur Other



Sanofi iOS Parkguiden Products and/or services

finder

Sanofi Android Parkguiden Products and/or services

finder

Sanofi iOS Phosphorus Mission (IN) Health game

Sanofi iOS Phosphorus Mission (SE) Health game

Sanofi iOS Phosphorus Mission for South Africa Health game

Sanofi Android PillReminder - Denk an mich Medication reminder

Sanofi iOS PillReminder – Denk an mich Medication reminder

Sanofi Android Primadose Medical calculator

Sanofi iOS Primadose Medical calculator

Sanofi iOS Pro Liver Health game

Sanofi iOS SANOFI AT A GLANCE Other

Sanofi Android SANOFI AT A GLANCE Other

Sanofi iOS Sanofi Diabetes (Australia) Medical reference

Sanofi Android Sanofi Diabetes (Australia) Medical reference

Sanofi iOS SANOFI Diabetes Manager Diabetes management

Sanofi iOS SANOFI IR Medical and health news

Sanofi Android Sanofi IR Medical and health news

Sanofi iOS Schilddruesen Monitor Medical information

Sanofi Android Schilddrüsen Monitor Medical information

Sanofi Android Sevelamer Medical calculator

Sanofi iOS SunSkin Medical information

Sanofi iOS TeriTaeglich Medical condition

management

Sanofi iOS Tram App Medical reference

Sanofi Android Tram App Medical reference

Sanofi Android Travel Tips Medical information

Sanofi iOS Travel Tips against counterfeit

medicines

Medical information

Sanofi Android Yummo Other



Sanofi iOS Yummo Adventures Health game

Sanofi iOS БЕБИ-ГИД Baby

Sanofi Android БЕБИ-ГИД Baby

Sanofi iOS Будущая Мама Pregnancy

Sanofi iOS Операция Фосфор Health game

Sanofi Android Операция Фосфор Health game

Sanofi iOS ЭпиДень Medical condition

management

Sanofi Android ЭпиДень Medical condition

management

Sanofi iOS 인의 미션 Health game

Sanofi Android 인의 미션 Health game


9. LIST OF FIGURES

Figure 1: Number of apps published by top Pharma companies 2013 and 2014 ........................................... 8

Figure 2: Pharma's all-time app downloads 2013 and 2014 ........................................................................... 9

Figure 3: Download share of top 5, 10 and 20 Pharma apps ........................................................................ 10

Figure 4: Download and MAU share by target group of Pharma apps ......................................................... 11

Figure 5: Pharma's app categories ................................................................................................................ 12

Figure 6: Differences between Pharma app portfolios and the mHealth app market.................................. 13

Figure 7: Pharma's platform choice and their user base............................................................................... 14

Figure 8: Number of markets targeted by Pharma's apps ............................................................................ 15

Figure 9: Number of apps published by Pharma per platform ..................................................................... 16

Figure 10: All-time app downloads per company and platform ................................................................... 17

Figure 11: Each Pharma company's top 3 apps as a share of the company's total downloads .................... 18

Figure 12: Monthly active users and share of MAU per Pharma company .................................................. 19

Figure 13: Target group - private vs. professional - shares per Pharma company ....................................... 20

Figure 14: Number of app publishers by company ....................................................................................... 20

Figure 15: Top 3 markets per company and their share of total downloads ................................................ 21

Figure 16: Abbot app - key metrics ............................................................................................................... 22

Figure 17: Abbot app - category shares ........................................................................................................ 23

Figure 18: AstraZeneca app - key metrics ..................................................................................................... 26

Figure 19: AstraZeneca app: category shares ............................................................................................... 26

Figure 20: Bayer Healthcare app - key metrics ............................................................................................. 29

Figure 21: Bayer Healthcare apps: category shares ...................................................................................... 29

Figure 22: Bristol-Myers Squibb app - key metrics........................................................................................ 32

Figure 23: Bristol-Myers Squibb app - category shares ................................................................................. 32

Figure 24: GlaxoSmithKline app - key metrics ............................................................................................... 35

Figure 25: Figure 9: GlaxoSmithKline app: category shares .......................................................................... 35

Figure 26: Johnson&Johnson app - key metrics ............................................................................................ 38

Figure 27: Johnson&Johnson app - category shares ..................................................................................... 38

Figure 28: Merck app - key metrics ............................................................................................................... 41

Figure 29: Merck app - category shares ....................................................................................................... 41

Figure 30: MSD app – key metrics ................................................................................................................. 44

Figure 31: MSD app - category shares ........................................................................................................... 44

Figure 32: Novartis app - key metrics ............................................................................................................ 46

Figure 33: Novartis app - category shares ..................................................................................................... 47

Figure 34: Pfizer app - key metrics ................................................................................................................ 50

Figure 35: Pfizer app - category shares ......................................................................................................... 50

Figure 36: Roche app - key metrics ............................................................................................................... 53

Figure 37: Roche app - category shares ........................................................................................................ 53

Figure 38: Sanofi Aventis app - key metrics .................................................................................................. 56

Figure 39: Sanofi Aventis app - category shares ........................................................................................... 56

- research2guidance · the mhealth app market has been experiencing new dynamics since the market...

Documents